| Biochemistry & Pharmacology Portfolio - FY 2007 Awards | ||||
| Grant | PI Name | Institution | Project Title | PO Name |
| 5R01 CA112519-02 | ALI-OSMAN, FRANCIS | DUKE UNIVERSITY | Novel Targeted Therapeutics for CNS Malignancies | LEES, ROBERT |
| 5R01 CA080195-09 | ARTEAGA, CARLOS L | VANDERBILT UNIVERSITY | Erbb2 targeted antitumor strategies in breast cancer | FORRY-SCHAUDIES, SUZANNE |
| 2R01 CA077091-04A2 | AU, JESSIE L-S | OHIO STATE UNIVERSITY | Telomeres, telomerase and chemotherapy: Bench to bedside | ARYA, SURESH |
| 5R01 CA104661-04 | AWASTHI, SANJAY | UNIVERSITY OF TEXAS ARLINGTON | Role of RALBP1 in Xenobiotic and Radiation Resistance | FORRY-SCHAUDIES, SUZANNE |
| 2R01 CA077495-09A1 | AWASTHI, SANJAY | UNIVERSITY OF TEXAS ARLINGTON | Mechanism of Drug Transport in Lung Cancer Cells | FORRY-SCHAUDIES, SUZANNE |
| 2R44 CA106137-02A1 | AYEHUNIE, SEYOUM | MATTEK CORPORATION | In Vitro Assay for Chemical Allergens | SONG, MIN-KYUNG |
| 5R01 CA122356-02 | BAE, YOU HAN | UNIVERSITY OF UTAH | Micelle surface engineering for active targeting by acidic tumor extracellular pH | FU, YALI |
| 5R01 CA101850-04 | BAE, YOU HAN | UNIVERSITY OF UTAH | Engineered intelligent micelle for tumor pH targeting | FU, YALI |
| 5R01 CA108975-02 | BAEK, SEUNG JOON | UNIVERSITY OF TENNESSEE KNOXVILLE | PPAR-gamma ligands in colorectal cancer | ARYA, SURESH |
| 5R01 CA075080-10 | BALDWIN JR, ALBERT S | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | NF-kappaB as a Therapeutic Target for Prostate Cancer | ARYA, SURESH |
| 1R01 CA111803-01A2 | BALK, STEVEN P | BETH ISRAEL DEACONESS MEDICAL CENTER | Targeting AR-NCoR Interaction in Prostate Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA118213-02 | BALTHASAR, JOSEPH P | STATE UNIVERSITY OF NEW YORK AT BUFFALO | Pharmacokinetic strategies to optimize IP chemotherapy | FU, YALI |
| 5R01 CA102688-04 | BARON, VERONIQUE T | SIDNEY KIMMEL CANCER CENTER | Validation of a New Target for Prostate Cancer Therapy | ARYA, SURESH |
| 1R21 CA121782-01A1 | BARTON, BEVERLY E | UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL | Cell-targeting peptide nucleic acids for hormone-refractory prostate cancer | FU, YALI |
| 1R01 CA124763-01A1 | BASU, SUJIT | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | The Role of Dopamine in Colon Cancer Neovascularization | FORRY-SCHAUDIES, SUZANNE |
| 5R21 CA118265-02 | BASU, SUJIT | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | The Neurotransmitter Dopamine and Gastric Cancer | SONG, MIN-KYUNG |
| 5R01 CA122383-02 | BATES, PAULA J | UNIVERSITY OF LOUISVILLE | Tumor-Targeting Oligonucleotides | LEES, ROBERT |
| 5R01 CA040570-20 | BECK, WILLIAM T | UNIVERSITY OF ILLINOIS AT CHICAGO | Characteristics of Multidrug Resistance in Human Tumors | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA114116-03 | BEDFORD, MARK T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Small Molecule Regulators of Arginine Methyltransferases | SONG, MIN-KYUNG |
| 5R01 CA106312-03 | BEERMAN, TERRY A | ROSWELL PARK CANCER INSTITUTE CORP | Cellular Responses to Cancer Drug-Induced Genomic Breaks | ARYA, SURESH |
| 5R01 CA106713-03 | BENBROOK, DORIS M. | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR | Mechanism of SHeA2 Action in Ovarian Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA097127-05 | BENEDICT, WILLIAM F | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | RB4 Intravesical Gene Therapy: Mechanisms of Cell Death | ARYA, SURESH |
| 5R01 CA036773-25 | BENZ, CHRISTOPHER | BUCK INSTITUTE FOR AGE RESEARCH | Therapeutic Modulation of Breast Cancer Oncogenes | ARYA, SURESH |
| 5R01 CA118408-03 | BERDIS, ANTHONY J | CASE WESTERN RESERVE UNIVERSITY | Non-natural Nucleoside Inhibitors of DNA Polymerases | LEES, ROBERT |
| 5R01 CA008010-44 | BERTINO, JOSEPH R | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Mechanism of Action of Folate Antagonist | WOLPERT, MARY K. |
| 1R01 CA123207-01A1 | BHALLA, KAPIL N | MEDICAL COLLEGE OF GEORGIA (MCG) | Histone Deacetylase Inhibitor Based Therapy of AML | ARYA, SURESH |
| 5R44 CA108392-03 | BISGROVE, DWAYNE ALLAN | SYSTEM BIOSCIENCES, LLC (SBI) | Functional Dissection of Signaling Pathways | SONG, MIN-KYUNG |
| 5R01 CA111542-03 | BJORNSTI, MARY-ANN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | SUMOylation and Cell Sensitivity to Top1 Poisons | ARYA, SURESH |
| 2R01 CA058755-13A1 | BJORNSTI, MARY-ANN | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | DNA Topoisomerase-Camptothecin Interactions | ARYA, SURESH |
| 5R01 CA085939-08 | BLACK, MARGARET E | WASHINGTON STATE UNIVERSITY | Improving Suicide Genes for Cancer Gene Therapy | ARYA, SURESH |
| 5U01 CA120458-02 | BLAGG, BRIAN S J | UNIVERSITY OF KANSAS LAWRENCE | Development and Evaluation of Purine and Coumarin Based Hsp90 Inhibitors` | LEES, ROBERT |
| 5R01 CA114393-03 | BLAGG, BRIAN S J | UNIVERSITY OF KANSAS LAWRENCE | HTS Assays for Hsp90 Inhibitors | SONG, MIN-KYUNG |
| 5U01 CA109265-02 | BLAGG, BRIAN S J | UNIVERSITY OF KANSAS LAWRENCE | Hsp90 Inhibitors | LEES, ROBERT |
| 5R01 CA115526-02 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | Vindoline and Vinblastine | LEES, ROBERT |
| 5R01 CA042056-24 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | Antitumor Antibiotics | LEES, ROBERT |
| 2R01 CA041986-20A1 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | The Antitumor Antibiotics CC-1065 and the Duocarmycins | LEES, ROBERT |
| 5R01 CA041101-23 | BOGER, DALE L | SCRIPPS RESEARCH INSTITUTE | Biologically Active Cyclic Peptides | LEES, ROBERT |
| 5R01 CA108558-04 | BOGLER, OLIVER | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Treatment of Malignant Gliomas with 2-5A-anti-hTR | ARYA, SURESH |
| 5R03 CA123004-02 | BOLD, RICHARD J | UNIVERSITY OF CALIFORNIA DAVIS | Targeting AKT as a novel therapy in pancreatic cancer | FORRY-SCHAUDIES, SUZANNE |
| 2R01 CA088986-05 | BOONS, GEERT-JAN | UNIVERSITY OF GEORGIA (UGA) | A fully synthetic carbohydrate-based cancer vaccine | LEES, ROBERT |
| 5R01 CA102792-05 | BOOTHMAN, DAVID A | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Use of Beta-Lapachone for Lung Cancer Chemotherapy | FU, YALI |
| 5P01 CA097323-05 | BRODEUR, GARRETT M | CHILDREN'S HOSPITAL OF PHILADELPHIA | Neuroblastoma Biology and Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA027440-28 | BRODIE, ANGELA M. | UNIVERSITY OF MARYLAND BALTIMORE | ANDROGEN SYNTHESIS INHIBITORS FOR PROSTATE CANCER | LEES, ROBERT |
| 5R01 CA116590-02 | BRONICH, TATIANA K | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Cross-linked Polymer Micelles in Cancer Therapy | FU, YALI |
| 5R01 CA106646-03 | BROWN, KATHLYNN C | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Diagnostic & targeting reagents for lung cancer | SONG, MIN-KYUNG |
| 5R01 CA105435-05 | BROWN, MILTON L. | GEORGETOWN UNIVERSITY | Sodium Channel Blockers as Inhibitors of Prostate Cancer | LEES, ROBERT |
| 1R43 CA130272-01 | BUDDE, RAYMOND J | HOUSTON PHARMACEUTICALS, INC. | Development of the first topo II inhibitor for brain tumors | LEES, ROBERT |
| 1R43 CA126318-01A1 | BUDDE, RAYMOND J | HOUSTON PHARMACEUTICALS, INC. | Thermally Targeted Delivery of DOX | SONG, MIN-KYUNG |
| 1R01 CA127258-01 | BURGER, ANGELIKA M | UNIVERSITY OF MARYLAND BALTIMORE | The BCA2 Ubiquitin E3 Ligase as a Target in Breast Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA099036-05 | BURKE, DANIEL J | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Identifying Inhibitors of the APC/C Using Yeast Mutants | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA108488-04 | BURKE, STEVEN D. | UNIVERSITY OF WISCONSIN MADISON | Expeditious Synthesis of Complexity and Diversity | LEES, ROBERT |
| 5R01 CA106673-03 | BURKE, STEVEN D. | UNIVERSITY OF WISCONSIN MADISON | Macrocyclic Enyne Methathesis and Its Applications | LEES, ROBERT |
| 5R44 CA110885-03 | BURKHART, CATHERINE A | CLEVELAND BIOLABS, INC. | N-myc Targeted Therapeutics for Childhood Neuroblastoma | SONG, MIN-KYUNG |
| 5R01 CA085935-07 | CABRAL, FERNANDO R | UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON | Tubulin Mutations and Paclitaxel Resistance | FU, YALI |
| 1R21 CA122327-01A1 | CAO, DELIANG | SOUTHERN ILLINOIS UNIVERSITY SCH OF MED | Aldose Reductase-Like-1, a Novel Hepatocellular Carcinoma Drug Resistant Protein | SONG, MIN-KYUNG |
| 5R01 CA114107-03 | CARDENAS-CORONA, MARIA E | DUKE UNIVERSITY | Signaling mechanisms by the rapamycin target: Tor kinase | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA116491-01A2 | CARRIER, FRANCE | UNIVERSITY OF MARYLAND BALTIMORE | Biomodulation of anticancer drugs targeting DNA | ARYA, SURESH |
| 5R01 CA051085-18 | CASERO, ROBERT A | JOHNS HOPKINS UNIVERSITY | Spermine N1-Acetylase Induction in Lung Cancers | WOLPERT, MARY K. |
| 1R41 CA126317-01A1 | CASTOR, TREVOR PERCIVAL | APHIOS CORPORATION | Alkylating Vitamin D Derivative | FU, YALI |
| 5R01 CA035635-22 | CHAIRES, JONATHAN B. | UNIVERSITY OF LOUISVILLE | Specificity of Intercalation Reactions | FU, YALI |
| 5R01 CA109821-04 | CHAMBERS, TIMOTHY C | UNIVERSITY OF ARKANSAS MED SCIS LTL ROCK | BcL-2 Proteins in Mechanism of Anti-mitotic Drug Action | ARYA, SURESH |
| 5R01 CA084480-07 | CHANEY, STEPHEN G | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Error-Prone Replicative Bypass of Platinum Adducts | WOLPERT, MARY K. |
| 5R01 CA089078-07 | CHANG, XIU-BAO | MAYO CLINIC COLL OF MED, MAYO CLINIC AZ | Mechanism of ATP-dependent transport by MRP1 protein | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA094851-05 | CHEN, JIANDONG | H. LEE MOFFITT CANCER CTR & RES INST | Pharmacological rescue of mutant p53 function | WOLPERT, MARY K. |
| 5R01 CA120272-02 | CHEN, JING | EMORY UNIVERSITY | Signaling and targeting of FGFR1 fusions in 8p11 myeloproliferative syndrome | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA113656-02 | CHEN, WEI | DUKE UNIVERSITY | Innovative Assays for Oncogenic Hedgehog Signaling | SONG, MIN-KYUNG |
| 5R01 CA100241-05 | CHENG, GENHONG | UNIVERSITY OF CALIFORNIA LOS ANGELES | The Apoptotic Role of MEKK1 in Cancer Chemotherapy | FORRY-SCHAUDIES, SUZANNE |
| 7R01 CA107078-05 | CHENG, JIN Q | H. LEE MOFFITT CANCER CTR & RES INST | Disruption of AKT Pathway for Cancer Intervention | LEES, ROBERT |
| 5R01 CA107078-04 | CHENG, JIN Q | UNIVERSITY OF SOUTH FLORIDA | Disruption of AKT Pathway for Cancer Intervention | LEES, ROBERT |
| 5R01 CA063477-12 | CHENG, YUNG-CHI | YALE UNIVERSITY | Nucleoside Analogs as Anticancer Compounds | SONG, MIN-KYUNG |
| 3R01 CA063477-11A1S1 | CHENG, YUNG-CHI | YALE UNIVERSITY | Nucleoside Analogs as Anticancer Compounds | SONG, MIN-KYUNG |
| 5R01 CA116428-03 | CHESNEY, JASON A | UNIVERSITY OF LOUISVILLE | Targeting of 6-Phosphofructo-2 kinase in Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA076193-10 | CHIANG, GARY G | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | Cellular Pharmacology of Rapamycin | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA119001-02 | CHIOSIS, GABRIELA | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Assays for rapid identification of Hsp70 modulators | SONG, MIN-KYUNG |
| 5R01 CA109518-03 | CHITAMBAR, CHRISTOPHER R | MEDICAL COLLEGE OF WISCONSIN | Cellular Targets for Gallium Compounds in Lymphoma | FORRY-SCHAUDIES, SUZANNE |
| 1R43 CA130228-01 | CHOI, ANTHONY H | BEXION PHARMACEUTICALS, INC. | A novel biotherapeutic treatment for prostate cancer | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA112446-01A2 | CHOU, KAI-MING | UNIVERSITY OF SOUTH ALABAMA | DNA Lesion Bypass Polymerases and Therapeutic Compounds | ARYA, SURESH |
| 1R01 CA129814-01 | CICHOWSKI, KAREN | BRIGHAM AND WOMEN'S HOSPITAL | Elucidating the role of the mTOR pathway in NF1-related tumorigenesis | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA024487-29 | CLARDY, JON | HARVARD UNIVERSITY (MEDICAL SCHOOL) | Applications of Natural Products to Chemical Biology | FU, YALI |
| 5R01 CA059021-15 | CLARDY, JON C. | HARVARD UNIVERSITY (MEDICAL SCHOOL) | Structural and Functional Studies on Proteins | LEES, ROBERT |
| 2R01 CA090853-06 | CLARET, FRANCOIS X | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Targeting JAB1 Oncogenic Function in Breast Cancer | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA123159-01A1 | COLE, DAVID J | MEDICAL UNIVERSITY OF SOUTH CAROLINA | TARGETING THE CASM ONCOGENE AS A NOVEL THERAPY FOR PANCREATIC CANCER | ARYA, SURESH |
| 2R01 CA074305-12 | COLE, PHILIP A | JOHNS HOPKINS UNIVERSITY | Chemical Approaches to Protein Phosphorylation | LEES, ROBERT |
| 5R01 CA065875-13 | COLEMAN, ROBERT S | OHIO STATE UNIVERSITY | Azinomycins - Total Synthesis and Mechanism of Action | LEES, ROBERT |
| 5R01 CA066561-11 | COLMAN, ROBERTA F. | UNIVERSITY OF DELAWARE | Glutathione S-Transferases: Novel Regulators of Cellular Stress and Apoptosis | SONG, MIN-KYUNG |
| 5R01 CA016783-32 | COLVIN, OLIVER MICHAEL | DUKE UNIVERSITY | Pharmacology of Cyclophosphamide and Other Alkylators | SONG, MIN-KYUNG |
| 1R21 CA124557-01A1 | CONNELL, PHILIP | UNIVERSITY OF CHICAGO | Inhibition of Recombination DNA Repair in Pancreatic Cancer Cells | SONG, MIN-KYUNG |
| 1R21 CA126903-01 | COUNTER, CHRISTOPHER M | DUKE UNIVERSITY | Developing inhibitors of RalA function for the treatment of pancreatic cancer | SONG, MIN-KYUNG |
| 1R01 CA121680-01A2 | COWAN, NICHOLAS | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Inhibition of the Tubulin Folding Pathway as a Novel Therapy for Cancer | SONG, MIN-KYUNG |
| 5R01 CA109550-04 | COX, ADRIENNE D | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Protein prenylation, oncogenesis and novel therapeutics | FORRY-SCHAUDIES, SUZANNE |
| 5R44 CA099217-03 | COX, GEORGE NORBERT | BOLDER BIOTECHNOLOGY, INC. | Long Acting VEGF BInding Proteins for Treating Cancer | LEES, ROBERT |
| 5R01 CA087660-08 | CRAVATT, BENJAMIN F | SCRIPPS RESEARCH INSTITUTE | Chemical Approaches for Activity Based Proteomics | FU, YALI |
| 5U19 CA052955-18 | CREWS, PHILLIP O | UNIVERSITY OF CALIFORNIA SANTA CRUZ | Targeted Discovery of Marine-derived Anticancer Leads | FU, YALI |
| 5R37 CA055254-17 | CROTEAU, RODNEY B | WASHINGTON STATE UNIVERSITY | BIOSYNTHESIS of Taxol | FU, YALI |
| 1R15 CA127888-01 | CRUPPER, SCOTT S | EMPORIA STATE UNIVERSITY | Secondary Metabolite Production in Sorangium cellulosum | FU, YALI |
| 5R01 CA097198-05 | CRYNS, VINCENT L. | NORTHWESTERN UNIVERSITY | Role of alphaB-Crystallin in Cancer Cell Death | FORRY-SCHAUDIES, SUZANNE |
| 5R21 CA115785-02 | CULLEN, JOSEPH J | UNIVERSITY OF IOWA | Mechanisms of Dicumarol-Induced Cytotoxicity | FU, YALI |
| 5R01 CA118562-02 | CUNNINGHAM, BRIAN T | UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN | Label-Free Screening Using Photonic Crystal Sensors for the Apoptotic Pathway | SONG, MIN-KYUNG |
| 5R01 CA098871-03 | CUSACK, JAMES C. | MASSACHUSETTS GENERAL HOSPITAL | The Role of NF-kappaB in Chemotherapy Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5U01 CA089566-07 | CUSHMAN, MARK S | PURDUE UNIVERSITY WEST LAFAYETTE | Novel Indenoisoquinoline Topoisomerase I Inhibitors | FU, YALI |
| 5R01 CA059750-12 | CUTLER, MARY L | HENRY M. JACKSON FDN FOR THE ADV MIL/MED | TOPOISOMERASE I AS AN ANTITUMOR DRUG TARGET | ARYA, SURESH |
| 2R01 CA077859-09 | DALTON, WILLIAM S | H. LEE MOFFITT CANCER CTR & RES INST | Drug Resistance in Multiple Myeloma | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA128002-01 | DAMMAI, VINCENT | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Cellular Factors Promoting Renal Cell Carcinoma | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA103823-29 | DANISHEFSKY, SAMUEL J | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Synthesis of Antiinfective Agents | LEES, ROBERT |
| 4R37 CA028824-29 | DANISHEFSKY, SAMUEL J | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Synthesis of Antitumor Natural Products | LEES, ROBERT |
| 5R01 CA113446-03 | DANKS, MARY K | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | Neural Progenitor Cells as Cancer Therapy Vectors | FU, YALI |
| 5R21 CA122963-02 | DARLING, THOMAS N | HENRY M. JACKSON FDN FOR THE ADV MIL/MED | Novel in vitro and xenograft models to study treatments for tuberous sclerosis | SONG, MIN-KYUNG |
| 5R01 CA115331-08 | DARMANI, NISSAR A | WESTERN UNIVERSITY OF HEALTH SCIENCES | MECHANISMS OF CANNABINOID'S ANTIEMETIC ACTIONS | FU, YALI |
| 5R01 CA107039-03 | DAWSON, MARCIA I | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | Rexinoid Synergy in Prostate Cancer Apoptosis | LEES, ROBERT |
| 5R01 CA090349-07 | DE BRABANDER, JEF KAREL | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Chemistry and Biology of Antitumor Natural Products | LEES, ROBERT |
| 5R01 CA109174-02 | DEBS, ROBERT J | CALIFORNIA PACIFIC MED CTR RES INSTITUTE | Developing Multi-Genic Anti-Breast Cancer Therapies | ARYA, SURESH |
| 1R01 CA124764-01A1 | DENMEADE, SAMUEL R | JOHNS HOPKINS UNIVERSITY | Fibroblast Activation Protein-alpha Activated Anti-Stromal Prodrug Therpay for Ca | FU, YALI |
| 5R33 CA112144-03 | D'ERRICO, FRANCESCO | YALE UNIVERSITY | Chemotherapy with injectable microdroplets | FU, YALI |
| 5R01 CA111422-03 | DMITROVSKY, ETHAN | DARTMOUTH COLLEGE | Cyclin D as a Retinoid Molecular Target | ARYA, SURESH |
| 5R01 CA081485-08 | DOLAN, M EILEEN | UNIVERSITY OF CHICAGO | Role of DNA In Protecting Against Secondary Leukemias | FORRY-SCHAUDIES, SUZANNE |
| 5R21 CA112436-02 | DORMIDONTOVA, ELENA | CASE WESTERN RESERVE UNIVERSITY | Design of Targeting Enhancement for Drug Delivery | FU, YALI |
| 5R01 CA115626-02 | DORR, ROBERT T | UNIVERSITY OF ARIZONA | Redox-Active Agents for Pancreatic Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5P01 CA094000-05 | EALICK, STEVEN E | CORNELL UNIVERSITY ITHACA | Rational Design of Inhibitors of Polyamine Synthesis | LEES, ROBERT |
| 1R01 CA117874-01A2 | EASTMAN, ALAN | DARTMOUTH COLLEGE | Mechanisms of Resistance to Cell Cycle Checkpoint Kinase Inhibitors | ARYA, SURESH |
| 5R13 CA124132-02 | EASTMAN, ALAN R | GORDON RESEARCH CONFERENCES | 2006 Molecular Therapeutics of Cancer Gordon Research Conference | ARYA, SURESH |
| 5R01 CA050224-14 | EASTMAN, ALAN R | DARTMOUTH COLLEGE | Cell Death Induced by Anticancer Agents | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA098568-04 | ERDREICH-EPSTEIN, ANAT | CHILDREN'S HOSPITAL LOS ANGELES | Brain tumor angiogenesis: Integrin ceramide signaling | ARYA, SURESH |
| 5R01 CA096839-05 | ERICKSON, LEONARD C | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Two Photon Imaging of Drug Uptake Efflux and Modulation | LEES, ROBERT |
| 5R01 CA112278-03 | ESKO, JEFFREY D | UNIVERSITY OF CALIFORNIA SAN DIEGO | Glycoside Inhibitors of Tumor Metastasis | FU, YALI |
| 5R01 CA086061-07 | ESSIGMANN, JOHN M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Mechanistic Comparison of Cisplatin with Synthetic DNA Repair-Shielding Anticancer | WOLPERT, MARY K. |
| 5R01 CA077743-10 | ESSIGMANN, JOHN M | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Design of Programmable Genotoxins | LEES, ROBERT |
| 5R01 CA110940-06 | ETZKORN, FELICIA A | VIRGINIA POLYTECHNIC INST AND ST UNIV | Designed Inhibitors of Pin1 in Mitosis | LEES, ROBERT |
| 5R01 CA104748-04 | EVERS, BERNARD MARK | UNIVERSITY OF TEXAS MEDICAL BR GALVESTON | Surgical Studies of Signaling Pathways in GI Cancers | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA112102-03 | FALLER, DOUGLAS V | BOSTON UNIVERSITY MEDICAL CAMPUS | Ras Oncoprotein-Targeted Therapy for Cancer | ARYA, SURESH |
| 2R56 CA078754-10 | FARRELL, NICHOLAS P | VIRGINIA COMMONWEALTH UNIVERSITY | Mechanistic Studies on New Platinum Clinical Agents | LEES, ROBERT |
| 5R01 CA077683-08 | FELIX, CAROLYN A | CHILDREN'S HOSPITAL OF PHILADELPHIA | ANTINEOPLASTIC v LEUKEMOGENIC EPIPODOPHYLLOTOXIN EFFECTS | FU, YALI |
| 5R37 CA044848-21 | FENICAL, WILLIAM H | UNIVERSITY OF CALIFORNIA SAN DIEGO | Antitumor-Antibiotics from Marine Microorganisms | FU, YALI |
| 5R01 CA109254-03 | FERNANDES, DANIEL J | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Drug-Induced Destabilization of Bcl-2 mRNA | ARYA, SURESH |
| 1R43 CA117291-01A2 | FEWELL, JASON G. | EXPRESSION GENETICS, INC. | Novel Combination Treatments For Brain Tumors | FU, YALI |
| 1R21 CA122298-01A1 | FISHEL, MELISSA L | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Chemosensitization of Pancreatic Tumors via Inhibition of a DNA BER Enzyme, Ape1 | ARYA, SURESH |
| 5R01 CA098712-05 | FISHER, PAUL B | COLUMBIA UNIVERSITY HEALTH SCIENCES | Novel Approaches for Pancreatic Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 1R43 CA130381-01 | FONG, PETER MARC | CARIGENT THERAPEUTICS | Long Circulating Targeted Nanoparticles for non-Hodgkin's Lymphoma Treatment | FU, YALI |
| 1R43 CA130388-01 | FRACZKIEWICZ, ROBERT | SIMULATIONS PLUS, INC. | Novel In Silico Models for ADMET Using Rapid Estimates of Quantum Chemical Descri | SONG, MIN-KYUNG |
| 5R21 CA122793-02 | FRANK, DAVID A | DANA-FARBER CANCER INSTITUTE | STAT3 in the Pathogenesis and Treatment of Pancreatic Cancer | ARYA, SURESH |
| 5R01 CA113796-02 | FRANK, MARKUS H. | CHILDREN'S HOSPITAL BOSTON | ABCB5 P-Glycoprotein in Cancer Multidrug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA090410-05 | FRIEDMAN, SIMON H | UNIVERSITY OF MISSOURI KANSAS CITY | Synthetic and Analytical Methods Targeting Telomerase | LEES, ROBERT |
| 5U01 CA060548-15 | FUCHS, PHILIP L | PURDUE UNIVERSITY WEST LAFAYETTE | Synthesis & Mechanism of Cephalostatin Anticancer Drugs | LEES, ROBERT |
| 5R01 CA072937-07 | GALLO, JAMES M. | TEMPLE UNIVERSITY | Interactions Between Cytotoxic and Antiangiogenic Drugs | SONG, MIN-KYUNG |
| 5R01 CA125153-02 | GANGJEE, ALEEM | DUQUESNE UNIVERSITY | Alpha Folate Receptor Mediated GARFTase Inhibitors as Selective Antitumor Agents | LEES, ROBERT |
| 5R01 CA114021-02 | GANGJEE, ALEEM | DUQUESNE UNIVERSITY | Antitumor Antimitotics That Reverse Tumor Resistance | LEES, ROBERT |
| 5R01 CA098850-05 | GANGJEE, ALEEM | DUQUESNE UNIVERSITY | Novel Single, Dual and Multitargeted Inhibitors of RTKs | FU, YALI |
| 1R01 CA122994-01A1 | GAO, JINMING | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Micellar Nanotherapeutics for Targeted Lung Cancer Therapy | FU, YALI |
| 5R01 CA119131-02 | GATES, KENT S | UNIVERSITY OF MISSOURI-COLUMBIA | Chemical and Biological Mechanisms of Leinamycin | LEES, ROBERT |
| 5R01 CA083925-07 | GATES, KENT S | UNIVERSITY OF MISSOURI-COLUMBIA | DNA Alkylation by Leinamycin | LEES, ROBERT |
| 5R01 CA109312-03 | GERA, JOSEPH F | SEPULVEDA RESEARCH CORPORATION | Mechanisms of AKT-dependent sensitivity to rapamycin | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA086357-08 | GERSON, STANTON L | CASE WESTERN RESERVE UNIVERSITY | Modulating Base Excision Repair in Tumor Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5P01 CA072765-10 | GEWIRTZ, ALAN M | UNIVERSITY OF PENNSYLVANIA | Examing Oligonucleotide Effects on Gene Expression | ARYA, SURESH |
| 5R21 CA116584-02 | GHANDEHARI, HAMID | UNIVERSITY OF MARYLAND BALTIMORE | Recombinant Polymers for Systemic Cancer Gene Therapy | FU, YALI |
| 5R01 CA107621-03 | GHANDEHARI, HAMID | UNIVERSITY OF MARYLAND BALTIMORE | Engineering Polymers For Gene Therapy of Head Cancer | FU, YALI |
| 5R01 CA100202-05 | GIANNAKAKOU, PARASKEVI | WEILL MEDICAL COLLEGE OF CORNELL UNIV | Antitubulin drugs: Mechanisms of action and resistance | FU, YALI |
| 1R01 CA112483-01A2 | GIBBS, RICHARD A | PURDUE UNIVERSITY WEST LAFAYETTE | Inhibition of Prenylated Protein Processing | LEES, ROBERT |
| 5R01 CA078819-08 | GIBBS, RICHARD A | PURDUE UNIVERSITY WEST LAFAYETTE | Chemical Probes of Protein Prenylation | LEES, ROBERT |
| 5R01 CA113344-03 | GLAZER, PETER M | YALE UNIVERSITY | Cisplatin Damage Response and Cell-to-cell Communication | WOLPERT, MARY K. |
| 5U01 CA102532-03 | GMEINER, WILLIAM H | WAKE FOREST UNIVERSITY HEALTH SCIENCES | DNA-DIRECTED EFFECTS OF FdUMP(N) | LEES, ROBERT |
| 5R01 CA082621-09 | GOLDMAN, I DAVID | YESHIVA UNIVERSITY | Carrier Mediated Antifolate Transport and Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA107311-03 | GOTTESFELD, JOEL M | SCRIPPS RESEARCH INSTITUTE | Polyamide-Chl inhibition of cancer cell proliferation | LEES, ROBERT |
| 1R01 CA124975-01A1 | GOYDOS, JAMES S | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Validation of Grm1 as a Therapeutic Target in Melanoma | SONG, MIN-KYUNG |
| 1R13 CA128063-01 | GRAINGER, DAVID W | UNIVERSITY OF UTAH | Conference Support: The 13th International Drug Delivery Symposium | FU, YALI |
| 5R01 CA101840-04 | GRANDIS, JENNIFER R | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Stat3 as a Therapeutic Target in Head and Neck Cancer | ARYA, SURESH |
| 2R01 CA093738-05A2 | GRANT, STEVEN | VIRGINIA COMMONWEALTH UNIVERSITY | NF-kappaB Inhibitors and Differentiation-Inducers in Leukemia | ARYA, SURESH |
| 5R01 CA063753-13 | GRANT, STEVEN | VIRGINIA COMMONWEALTH UNIVERSITY | Promotion of Nucleoside Analog Induced Apoptosis by HDIs | FORRY-SCHAUDIES, SUZANNE |
| 1R21 CA125327-01 | GRINSTAFF, MARK W | BOSTON UNIVERSITY | Nanoscale Functional Dendrimer-DNA Assemblies | FU, YALI |
| 1R01 CA124756-01 | GROMEIER, MATTHIAS | DUKE UNIVERSITY | Targeting Translation Control in Malignant Glioma | ARYA, SURESH |
| 5R01 CA114001-03 | GUNTHER, EDWARD J | PENNSYLVANIA STATE UNIV HERSHEY MED CTR | Preclinical Modeling of Latent Breast Cancer in Mice | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA109582-03 | GUPTA, KALPNA | UNIVERSITY OF MINNESOTA TWIN CITIES | Opioid and Breast Cancer Growth and Metastasis | FORRY-SCHAUDIES, SUZANNE |
| 7R01 CA101988-04 | GUSTAFSON, DANIEL L | COLORADO STATE UNIVERSITY-FORT COLLINS | Dual Compartmental Targeting of Cancer | SONG, MIN-KYUNG |
| 5R01 CA101988-03 | GUSTAFSON, DANIEL L | UNIVERSITY OF COLORADO DENVER/HSC AURORA | Dual Compartmental Targeting of Cancer | SONG, MIN-KYUNG |
| 5R01 CA109181-04 | HALDAR, SUBRATA | CASE WESTERN RESERVE UNIVERSITY | Molecular Targeting of Bcl-xL Pathway in Cancer | ARYA, SURESH |
| 5R01 CA089362-06 | HAMMERLING, ULRICH G | SLOAN-KETTERING INSTITUTE FOR CANCER RES | NOVEL RECEPTORS OF VITAMIN A IN THE CYTOPLASM | LEES, ROBERT |
| 5R01 CA057530-16 | HANIGAN, MARIE H | UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR | Significance of GGT Expression in Tumors | WOLPERT, MARY K. |
| 5P01 CA097132-05 | HANNUN, YUSUF AWNI | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Sphingolipids in Cancer Therapy and Angiogenesis | ARYA, SURESH |
| 5R44 CA096409-03 | HANSEN, BRIAN N | AEROPHASE, INC. | Aerosol Therapy for Lung Cancer | FU, YALI |
| 5R01 CA100560-03 | HAUGEN, BRYAN R | UNIVERSITY OF COLORADO DENVER/HSC AURORA | Thiazolidinediones as Thyroid Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA097342-05 | HAWTHORNE, M FREDERICK | UNIVERSITY OF MISSOURI-COLUMBIA | Liposome Delivery of Boron for BNCT | FU, YALI |
| 1R01 CA122065-01A1 | HAZLEHURST, LORI A | H. LEE MOFFITT CANCER CTR & RES INST | Role of Bim in mediating CAM-DR in hematopoietic tumors | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA116566-01A2 | HECHT, SIDNEY M | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Inhibitors of p90Rsk | LEES, ROBERT |
| 5R01 CA077359-10 | HECHT, SIDNEY MICHAEL | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Elaboration of Modified Proteins Using Misacylated tRNAs | FU, YALI |
| 5R01 CA077284-09 | HECHT, SIDNEY MICHAEL | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | Synthesis of Bleomycin Group Antibiotics and Analogues | LEES, ROBERT |
| 1R01 CA128803-01 | HEMANN, MICHAEL T | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | Identifying determinants of chemotherapeutic response in vivo | ARYA, SURESH |
| 3R01 CA098459-03S2 | HEMENWAY, CHARLES S | TULANE UNIVERSITY OF LOUISIANA | Targeted therapy for 11q23 acute leukemias. | ARYA, SURESH |
| 1R01 CA120439-01A2 | HERGENROTHER, PAUL J | UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN | Small Molecule Activators of Procaspases as Anti-Cancer Agents | LEES, ROBERT |
| 1R43 CA128270-01A1 | HERWEIJER, HANS | MIRUS BIO CORPORATION | Targeting of siRNAs, genes and drugs to cancer cells | FU, YALI |
| 5R01 CA122608-02 | HIGGINS, JONATHAN M | BRIGHAM AND WOMEN'S HOSPITAL | Development of a haspin kinase assay for high throughput drug screening | SONG, MIN-KYUNG |
| 5R01CA105305-04 | HIMES, RICHARD H | UNIVERSITY OF KANSAS LAWRENCE | A Yeast Model for Determining Tubulin-drug Interactions | FU, YALI |
| 5R01CA112570-04 | HO, SHUK-MEI | UNIVERSITY OF CINCINNATI | Progesterone-mediated protection against ovarian cancer | ARYA, SURESH |
| 1R01CA124898-01A1 | HORWITZ, SUSAN B | YESHIVA UNIVERSITY | H/D Exchange Coupled to MS to Study Drug-Induced Change in Microtuble Structure | FU, YALI |
| 5R01CA105039-04 | HOSTETLER, KARL Y | VETERANS MEDICAL RESEARCH FDN/SAN DIEGO | Nucleoside Phosphonate Analogs and HPV Positive Cancers | FORRY-SCHAUDIES, SUZANNE |
| 2R01CA087952-06A1 | HOUGHTON, JANET A | CLEVELAND CLINIC LERNER COL/MED-CWRU | TRAIL Therapy for Rhabdomyosacrcoma | ARYA, SURESH |
| 7R01CA032613-25 | HOUGHTON, JANET A | CLEVELAND CLINIC LERNER COL/MED-CWRU | SELECTIVE THERAPY FOR COLON CARCINOMA | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA077776-09 | HOUGHTON, PETER J | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | Rapamycin-induced Selective Apoptosis in Malignant Cells | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA095298-06 | HOWELL, STEPHEN B | UNIVERSITY OF CALIFORNIA SAN DIEGO | Cisplatin resistance mediated by cooper export pathways | WOLPERT, MARY K. |
| 5R01CA113859-02 | HU, MICKEY C-T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | The Role of Regulation of FOXO3a in Tumor Suppression | ARYA, SURESH |
| 1R01CA124974-01 | HUANG, JING | UNIVERSITY OF CALIFORNIA LOS ANGELES | Exploiting TOR Signaling for Cancer Drug Discovery | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA085563-06 | HUANG, PENG | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Superoxide, ROS, and novel targets for cancer therapy | FORRY-SCHAUDIES, SUZANNE |
| 1R21CA132684-01A2 | HUANG, XI | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Role of Estrogen and Iron in Breast Cancer | WOLPERT, MARY K. |
| 1R01CA116402-01A1 | HUNTER, TONY | SALK INSTITUTE FOR BIOLOGICAL STUDIES | Checkpoint Kinase Chk1 in Cancer Biology and Therapy | ARYA, SURESH |
| 1R43CA130193-01A1 | HUTCHINSON, CHARLES R | CENTROSE, LLC | cardiac neoglycosides as cancer drugs | LEES, ROBERT |
| 5R01CA104574-04 | ILIOPOULOS, OTHON | MASSACHUSETTS GENERAL HOSPITAL | Molecular targets of hypoxia in signaling cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109256-04 | IONOV, YURIJ | ROSWELL PARK CANCER INSTITUTE CORP | Using NMD to identify Mutated genes in colon cancer | ARYA, SURESH |
| 1R13CA128082-01 | IRELAND, CHRIS M. | UNIVERSITY OF UTAH | US-Japan Seminar - Frontiers in Marine Natural Products Research | FU, YALI |
| 5U19CA067786-13 | IRELAND, CHRIS M. | UNIVERSITY OF UTAH | ANTICANCER AGENTS FROM UNIQUE NATURAL PRODUCTS SOURCES | FU, YALI |
| 5R01CA036622-25 | IRELAND, CHRIS M. | UNIVERSITY OF UTAH | Antineoplastic Agents from Marine Organisms | FU, YALI |
| 1R01CA127378-01A1 | ISHOV, ALEXANDER M | UNIVERSITY OF FLORIDA | Function of Daxx in mitosis that determines paclitaxel sensitivity in breast canc | SONG, MIN-KYUNG |
| 5U19CA113341-03 | JAFFEE, ELIZABETH M | JOHNS HOPKINS UNIVERSITY | Combinational Immunotherapies to Amplify Vaccine Induce* | WOLPERT, MARY K. |
| 7R01CA081057-09 | JAISWAL, ANIL KUMAR | UNIVERSITY OF MARYLAND BALTIMORE | Mechanisms of Bioreductive Drugs Activation | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA081057-08 | JAISWAL, ANIL KUMAR | BAYLOR COLLEGE OF MEDICINE | Mechanisms of Bioreductive Drugs Activation | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA130402-01A1 | JANSEN, BURKHARD | NOVELIX PHARMACEUTICALS, INC. | Directed Synergy: A New Strategy to Combine Targeted Therapeutics | FU, YALI |
| 1R15CA108864-01A2 | JASTI, BHASKARA RAO | UNIVERSITY OF THE PACIFIC-STOCKTON | Amphiphilic Micellar Carriers with Integrin Binding Motives for Targeted Delivery | FU, YALI |
| 5R01CA116642-03 | JAY, DANIEL G. | TUFTS UNIVERSITY BOSTON | INHIBITING SURFACE HSP90 TO LIMIT METASTASIS | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA116322-01A2 | JI, LIN X | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Tumor and PTK-Targeted Therapy by FUS1 and PTK inhibitor | SONG, MIN-KYUNG |
| 1R01CA109208-01A2 | JIN, ZHENDONG | UNIVERSITY OF IOWA | Total Synthesis of Anticancer Agents Superstolides A & B | LEES, ROBERT |
| 5R01CA057291-15 | JORDAN, MARY A | UNIVERSITY OF CALIFORNIA SANTA BARBARA | Mechanisms of Action of Anti-Mitotic Drugs | FU, YALI |
| 5R01CA095317-03 | JOSHI, HARISH C | EMORY UNIVERSITY | Novel anti-melanoma agents and their mechanism of action | FU, YALI |
| 5R01CA040081-19 | JOULLIE, MADELEINE M | UNIVERSITY OF PENNSYLVANIA | Didemnins and Ustiloxins as Probes of Cell Proliferation | LEES, ROBERT |
| 1R01CA115674-01A1 | JOVE, RICHARD | CITY OF HOPE/BECKMAN RESEARCH INSTITUTE | Inhibitors in Src Signaling for Antitumor Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA116591-02 | KABANOV, ALEXANDER V | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Polymer Based Gene Delivery | FU, YALI |
| 2R01CA089225-05 | KABANOV, ALEXANDER V | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Interactions of Pluronic block copolymers in drug resistant cancer | FU, YALI |
| 5R01CA100451-05 | KANDEL, JESSICA J | COLUMBIA UNIVERSITY HEALTH SCIENCES | Acquired Resistance to VEGF blockade in Wilms tumor | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA121482-01A1 | KARPEISKY, ALEXANDER | MBC RESEARCH, INC. | Novel bisphosphonates for prostate cancer therapy | LEES, ROBERT |
| 5R01CA085972-07 | KAUFMANN, SCOTT H | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | Preclinical Evaluation of Bcr/Abl-Directed Tyrphostins | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA069008-13 | KAUFMANN, SCOTT H | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | Role of Proteases in Therapy-Induced Apoptosis | ARYA, SURESH |
| 5R01CA106298-04 | KELLEY, MARK R | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Imbalancing DNA BER to enhance Ovarian Tumor Sensitivity | ARYA, SURESH |
| 5R01CA041233-22 | KERBEL, ROBERT S | SUNNYBROOK & WOMEN'S COLL HLTH SCIS CTR | Exploiting Angiogenesis for Induction of Tumor Dormancy | WOLPERT, MARY K. |
| 2R01CA077248-10A1 | KHOSLA, CHAITAN | STANFORD UNIVERSITY | Bacterial Aromatic Polyketide Synthases | FU, YALI |
| 5R01CA066736-13 | KHOSLA, CHAITAN S | STANFORD UNIVERSITY | Engineered Biosynthesis of Novel Macrolactone Polyketide | FU, YALI |
| 5R01CA107070-04 | KIM, SUNG WAN | UNIVERSITY OF UTAH | RGD-Polymer Targeting Plasmid to Angiogenic Endothelium | FU, YALI |
| 1P01CA125066-01A1 | KINGHORN, A DOUGLAS | OHIO STATE UNIVERSITY | Discovery of Anticancer Agents of Diverse Natural Orgin | FU, YALI |
| 5R01CA069571-12 | KINGSTON, DAVID G | VIRGINIA POLYTECHNIC INST AND ST UNIV | STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS | FU, YALI |
| 5R44CA109864-03 | KIRKPATRICK, LYNN | PROLX PHARMACEUTICALS CORPORATION | PI-3 kinase inhibitor PX-866 as anticancer therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA022215-30 | KISHI, YOSHITO | HARVARD UNIVERSITY | Synthesis of Antitumor Natural Products | LEES, ROBERT |
| 1R01CA124634-01A1 | KISSELEV, ALEXEI F | DARTMOUTH COLLEGE | Different active sites of the proteasome as drug targets in cancer | ARYA, SURESH |
| 1R21CA124811-01A1 | KLINGE, CAROLYN M. | UNIVERSITY OF LOUISVILLE | Regulation of miRNA expression in breast cancer cells | SONG, MIN-KYUNG |
| 5R01CA089325-06 | KMIEC, ERIC B | UNIVERSITY OF DELAWARE | Regulation of Targeted Gene Correction | ARYA, SURESH |
| 5R01CA120792-02 | KOIDE, KAZUNORI | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Chemical Approaches for the Discovery of New Cancer Therapeutic Targets | LEES, ROBERT |
| 5R01CA042385-22 | KOLESNICK, RICHARD N | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Targeting KSR to Treat Pancreatic Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA095701-05 | KORN, WOLFGANG MICHAEL | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | The Adenovirus Receptor CAR in Epithelial Malignancies | ARYA, SURESH |
| 5R01CA098505-03 | KOUTCHER, JASON | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Cytocidal Therapy In Vivo for Drug-Resistant Tumors | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109164-04 | KOZLOWSKI, MARISA C | UNIVERSITY OF PENNSYLVANIA | Synthesis of Novel Anticancer Agents | LEES, ROBERT |
| 1U01CA120475-01A1 | KOZMA, SARA C | UNIVERSITY OF CINCINNATI | The Role of mTOR Signaling in Hepatocellular Carcinogenesis | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA104710-05 | KRAFT, ANDREW S | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Mechanisms by which Proteasome Enhance Apoptosis | ARYA, SURESH |
| 5R01CA112091-03 | KRAG, DAVID N | UNIVERSITY OF VERMONT & ST AGRIC COLLEGE | Targeted Enzymes for Prodrug Therapy | SONG, MIN-KYUNG |
| 5R01CA114104-02 | KRIDEL, STEVEN J | WAKE FOREST UNIVERSITY HEALTH SCIENCES | Fatty acid synthase inhibitors and prostate cancer | FORRY-SCHAUDIES, SUZANNE |
| 1P01CA129243-01 | KRIS, MARK G | SLOAN-KETTERING INSTITUTE FOR CANCER RES | New Targets for Therapy for Adenocarcinoma of the Lung | ARYA, SURESH |
| 5R01CA106655-03 | KRISE, JEFFREY P | UNIVERSITY OF KANSAS LAWRENCE | Analysis of Intracellular Drug Sequestration | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA104286-04 | KROLL, DAVID J | RESEARCH TRIANGLE INSTITUTE | Pure Flavonolignans from S. marianum in Prostate Cancer | FU, YALI |
| 5R01CA114574-02 | KRUH, GARY D | FOX CHASE CANCER CENTER | Functions of MRP2 and MRP3 in Drug Disposition | SONG, MIN-KYUNG |
| 5R01CA095030-03 | KRUPENKO, SERGEY A | MEDICAL UNIVERSITY OF SOUTH CAROLINA | FDH: A Novel Determinant of Tumor Suppression | ARYA, SURESH |
| 5R01CA104729-05 | KRYNETSKIY, EVGENY | TEMPLE UNIVERSITY | HMGB1/2 and Cellular Response to Fraudulent Nucleosides | ARYA, SURESH |
| 1R43CA130224-01 | KUMAR, NALIN | UHV TECHNOLOGIES, INC. | A Two Hybrid System Based Yeasy Screen for Agents that Affect DNA Damage Checkpoi | SONG, MIN-KYUNG |
| 1R03CA129786-01 | KUMARESAN, PAPPANAICKEN | UNIVERSITY OF CALIFORNIA DAVIS | Identification of pancreatic cancer specific high affinity targeting ligands | LEES, ROBERT |
| 5R01CA089541-04 | KUO, MACUS T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Genomic Instability and Evolution of Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA079085-05 | KUO, MACUS T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Redox Regulation of Multidrug Resistance Gene Expression | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA102264-04 | KUPPUSAMY, PERIANNAN | OHIO STATE UNIVERSITY | In Vivo EPR Imaging of Redox Status and Thiols in Tumor | LEES, ROBERT |
| 5R01CA107575-04 | KYPRIANOU, NATASHA | UNIVERSITY OF KENTUCKY | Anoikis Effect by Quinazolines on Prostate Growth | ARYA, SURESH |
| 7R21CA121751-02 | LABHASETWAR, VINOD D | CLEVELAND CLINIC LERNER COL/MED-CWRU | Drug Resistance in Cancer Therapy | FU, YALI |
| 1R21CA128501-01 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | High affinity ligand to deliver nanoparticle drugs to lymphoid cancers | FU, YALI |
| 5R01CA115483-03 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | Therapeutic Targeting Agents for Ovarian Cancer | FU, YALI |
| 5U19CA113298-03 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | Targeting Agents for Human and Canine Lymphoma | SONG, MIN-KYUNG |
| 5R01CA098116-05 | LAM, KIT S | UNIVERSITY OF CALIFORNIA DAVIS | c-src inhibitors from novel encoded chemical libraries | FU, YALI |
| 1R01CA120847-01A1 | LAMBERT, PAUL F | UNIVERSITY OF WISCONSIN MADISON | Role of Estrogen in Cervical Cancer | FORRY-SCHAUDIES, SUZANNE |
| 2R01CA037109-18A2 | LAMPIDIS, THEODORE J | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | Anti-tumor Activity of Sugar Analogs via Blocking Glycolysis vs Glycosylation | FORRY-SCHAUDIES, SUZANNE |
| 1R41CA126155-01A1 | LANDRY, CHRISTOPHER | APOLLO SRI, LLC | Improving the Transfer of ERK siRNA Constructs Using Nanoporous Silica | FU, YALI |
| 5R01CA113843-03 | LAVIE, ARNON | UNIVERSITY OF ILLINOIS AT CHICAGO | Enhancing the efficacy of nucleoside analogs | FU, YALI |
| 5P01CA078039-08 | LAZO, JOHN S | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Combinatorial Approaches for Novel Anticancer Agents | LEES, ROBERT |
| 5R01CA076560-06 | LEBIODA, LUKASZ | UNIVERSITY OF SOUTH CAROLINA AT COLUMBIA | Thymidylate Synthases: Modes of Catalysis and Inhibition | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA100816-04 | LEE, HO-YOUNG | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Novel Strategy for Lung Cancer Treatment using IGFBP-3 | ARYA, SURESH |
| 5R01CA017625-30 | LEE, KUO-HSIUNG | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | PLANT ANTITUMOR AGENTS | FU, YALI |
| 5R01CA095673-05 | LEE, ROBERT J. | OHIO STATE UNIVERSITY | Targeted Liposomal Doxorubicin Delivery to Leukemia | FU, YALI |
| 1R01CA129974-01A1 | LETAI, ANTHONY G | DANA-FARBER CANCER INSTITUTE | A Novel Strategy for Defining and Targeting Cancer Addiction to Anti-Apoptotic BC | ARYA, SURESH |
| 5R01CA109481-04 | LI, FENGZHI | ROSWELL PARK CANCER INSTITUTE CORP | Survivin expression and cancer cell drug resistance | FU, YALI |
| 5R01CA109574-03 | LI, KAIYI | BAYLOR COLLEGE OF MEDICINE | RNAi-Based Therapy of Hepatocellular Carcinoma | ARYA, SURESH |
| 1R21CA128415-01 | LI, SONG | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | Nanosized Delivery System for Site-Specific Drug Release | FU, YALI |
| 5R01CA111448-03 | LICHTENSTEIN, ALAN K | BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE | Sensitivity Multiple Myeloma Cells to mTOR Inhibitors | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA124001-01A2 | LIN, XINLI | PROTEOMTECH, INC. | p53 Fusion Protein as an Oncology Therapeutic | FU, YALI |
| 5R01CA098536-04 | LINDNER, DANIEL J | CLEVELAND CLINIC LERNER COL/MED-CWRU | Nitrosylcobalamin - A Novel Chemotherapeutic Agent | FORRY-SCHAUDIES, SUZANNE |
| 5R37CA034992-25 | LIPPARD, STEPHEN J | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | CHEMISTRY AND BIOLOGY OF PLATINUM ANTICANCER DRUGS | LEES, ROBERT |
| 1R01CA127535-01 | LIU, CHENG | SCRIPPS RESEARCH INSTITUTE | Cysteine Protease Network in Tumor Progression and Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA100211-05 | LIU, JUN O. | JOHNS HOPKINS UNIVERSITY | NF-kappaB Signaling Pathway Probed with Natural Products | FU, YALI |
| 5R01CA078743-11 | LIU, JUN O. | JOHNS HOPKINS UNIVERSITY | Inhibition of Angiogenesis by TNP 470 and Ovalicin | LEES, ROBERT |
| 5R01CA102463-04 | LIU, LEROY F | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Mechanism of action of TOP2-directed anticancer drugs | FU, YALI |
| 5R01CA039662-22 | LIU, LEROY F | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Mechanisms of Action in Antitumor Drugs | FU, YALI |
| 5R01CA119007-02 | LIVANT, DONNA L | UNIVERSITY OF MICHIGAN AT ANN ARBOR | PHSCN Therapies to Prevent Prostate Cancer Progression | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA123495-02 | LJUBIMOVA, JULIA Y | CEDARS-SINAI MEDICAL CENTER | Tumor drug delivery systems based on polymalic acid | FU, YALI |
| 5R01CA078885-10 | LOEB, LAWRENCE A | UNIVERSITY OF WASHINGTON | Creating Mutant Enzymes for Gene Therapy of Cancer | WOLPERT, MARY K. |
| 1R01CA123063-01A1 | LOKESHWAR, VINATA B | UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | Glycosaminoglycan-based inhibitors for treatment of prostate cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R44CA110535-03 | LOWERY, ROBERT G | BELLBROOK LABS, LLC | Generic Fluorescent HTS Assay for Kinases and ATPases | SONG, MIN-KYUNG |
| 5R44CA103133-04 | LU, ZE | OPTIMUM THERAPEUTICS, LLC | Tumor-priming Microparticles for Pancreatic Cancer | FU, YALI |
| 5R44CA096390-03 | LUKA, JANOS | TREVIGEN, INC. | Development of a standard high throughput comet assay | SONG, MIN-KYUNG |
| 5R01CA118975-02 | LUPU, RUTH F | EVANSTON NORTHWESTERN HEALTHCARE | Cyr61-induced breast cancer: Clinical relevance and therapeutic development | SONG, MIN-KYUNG |
| 5R01CA116623-03 | LUPU, RUTH F | EVANSTON NORTHWESTERN HEALTHCARE | Fatty Acid Synthase: Characterization as a Novel Molecular Target for Breast Can* | FORRY-SCHAUDIES, SUZANNE |
| 2R44CA107653-03A2 | MA, DANGSHE | PROGENICS PHARMACEUTICALS, INC. | PSMA Antibody-Drug Conjugate for Prostate Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R44CA114995-03 | MA, HAICHING | REACTION BIOLOGY CORPORATION | Kinome Drug Bioassay Platform | SONG, MIN-KYUNG |
| 5R01CA112075-03 | MANCHESTER, MARIANNE | SCRIPPS RESEARCH INSTITUTE | USING VIRAL NANOPARTICLES TO TARGET CANCER | FU, YALI |
| 5R01CA109451-03 | MARINI, FRANK C | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Gene Delivery Vehicles for Cancer Gene Therapy | FU, YALI |
| 1R41CA126001-01A1 | MARKLAND, FRANCIS S | MOLECULAR EXPRESS, INC. | Development of a combination therapy for the treatment of prostate cancer | FORRY-SCHAUDIES, SUZANNE |
| 1R41CA121452-01A1 | MARKLAND, FRANCIS S | MOLECULAR EXPRESS, INC. | Liposomal Disintegrin: Novel and Effective Antitumor Agent Phase I | FU, YALI |
| 1R43CA124022-01A1 | MARTINEZ, EDUARDO J | MEDROS, INC. | High Throughput Drug Screening in Drosophila for Novel Cancer Therapeutics | SONG, MIN-KYUNG |
| 5R01CA053535-16 | MATHERLY, LARRY H. | WAYNE STATE UNIVERSITY | Molecular Regulation of Folate and Antifolate Transport | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA120227-02 | MATTERN, MICHAEL R | PROGENRA, INC. | Ubiquitin E3 ligases and apoptosis in cancer drug discovery | SONG, MIN-KYUNG |
| 2R44CA115205-02 | MATTERN, MICHAEL R | PROGENRA, INC. | Molecular screens for pVHL-associated isopeptidase VDU1 | SONG, MIN-KYUNG |
| 1R01CA125392-01 | MATTS, ROBERT L | OKLAHOMA STATE UNIVERSITY STILLWATER | Identification of Natural Product Inhibitors of Hsp90 as Chemotherapeutic Agents | FU, YALI |
| 5R01CA100895-04 | MAURER, BARRY J | CHILDREN'S HOSPITAL LOS ANGELES | Novel Ceramide-based Chemotherapy for Acute Leukemia | SONG, MIN-KYUNG |
| 2R01CA096090-05A2 | MAYO, KEVIN H | UNIVERSITY OF MINNESOTA TWIN CITIES | Dibenzofuran-based Anginex Mimetics that Target Galectin-1 | LEES, ROBERT |
| 5R01CA098195-05 | MC CUBREY, JAMES A | EAST CAROLINA UNIVERSITY | Ras/Raf & PI3K/Akt Induced Breast Cancer Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 1R21CA128406-01 | MCDEVITT, MICHAEL R | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Novel Nano-Constructs to Target and Destroy Tumor Neovasculature | FU, YALI |
| 5R01CA111468-02 | MCGUIRE, JOHN J | ROSWELL PARK CANCER INSTITUTE CORP | Enhancement of methotrexate uptake in childhood ALL | WOLPERT, MARY K. |
| 1R15CA125602-01 | MCINTOSH, MATTHIAS C. | UNIVERSITY OF ARKANSAS AT FAYETTEVILLE | Novel Approaches to Anticancer Targets | LEES, ROBERT |
| 1R01CA120383-01A1 | MCIVOR, R SCOTT | UNIVERSITY OF MINNESOTA TWIN CITIES | Transposon Mediated Gene Therapy for Colorectal Cancer | ARYA, SURESH |
| 5R01CA060803-14 | MCIVOR, R SCOTT | UNIVERSITY OF MINNESOTA TWIN CITIES | Methotrexate Resistance Gene Expression | WOLPERT, MARY K. |
| 2P01CA095471-06 | MCKNIGHT, STEVEN L | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | A Concerted Chemical, Biophysical and Molecular Biological Attack of Intracellul* | LEES, ROBERT |
| 5R01CA096652-05 | MCMURRAY, JOHN S | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | The Development of Stat3 Inhibitors | LEES, ROBERT |
| 1R21CA116014-01A2 | MEDINA-KAUWE, LALI K | CEDARS-SINAI MEDICAL CENTER | A NOVEL TARGETED THERAPEUTIC USING VIRAL CAPSID PROTEIN | FU, YALI |
| 5R01CA111196-02 | MEDVECZKY, PETER G. | UNIVERSITY OF SOUTH FLORIDA | MODULATION OF ONCOGENIC AGENTS BY MARIJUANA | FU, YALI |
| 5R01CA077612-09 | MERAJVER, SOFIA DIANA | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Prevention of Mammary Cancer in Her-2neu Transgenic Mice | WOLPERT, MARY K. |
| 5R01CA100687-04 | MERUELO, DANIEL | NEW YORK UNIVERSITY SCHOOL OF MEDICINE | Sindbis Vectors For Advanced Pancreatic Cancer Therapy | ARYA, SURESH |
| 5R01CA116020-02 | MEYERSON, MATTHEW L | DANA-FARBER CANCER INSTITUTE | Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma | SONG, MIN-KYUNG |
| 5R01CA069003-11 | MEYN, RAYMOND E | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Anticancer Drug Resistance by Bcl-2 Oncogene Expression | FORRY-SCHAUDIES, SUZANNE |
| 3R33CA101622-03S1 | MILLER, CHARLES A | TULANE UNIVERSITY OF LOUISIANA | Evaluating Drug Toxicity in Humanized Yeast | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA082785-08 | MILLER, PAUL S. | JOHNS HOPKINS UNIVERSITY | Repair of Interstrand Cross-linked Synthetic DNA | FU, YALI |
| 5R01CA111766-02 | MINKO, TAMARA | RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK | Molecular Targeting of Drug Delivery System to Cancer | FU, YALI |
| 5R01CA100098-04 | MINKO, TAMARA | RUTGERS THE ST UNIV OF NJ NEW BRUNSWICK | Targeted Proapoptotic Anticancer Drug Delivery System | FU, YALI |
| 5P01CA078048-09 | MITCHISON, TIMOTHY J | HARVARD UNIVERSITY (MEDICAL SCHOOL) | Probing Cell Division with Synthetic Chemistry | ARYA, SURESH |
| 5R01CA096984-04 | MIXSON, A. JAMES | UNIVERSITY OF MARYLAND BALTIMORE | Gene Delivery of P53 in a Tumor-bearing Mouse Model | WOLPERT, MARY K. |
| 5R01CA077474-08 | MIYAMOTO, SHIGEKI | UNIVERSITY OF WISCONSIN MADISON | Mechanism of NF-kappaB Activation by DNA Damage | FU, YALI |
| 1R01CA122216-01A1 | MOASSER, MARK M | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | Understanding resistance to HER family tyrosine kinase inhibitors | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA122417-01A2 | MOBASHERY, SHAHRIAR | UNIVERSITY OF NOTRE DAME | Intervention of Disease by Selective Gelatinase Inhibitors | LEES, ROBERT |
| 1R01CA109389-01A2 | MOHAMMAD, RAMZI M | WAYNE STATE UNIVERSITY | Specific Targets for Pancreatic Cancer Therapy | ARYA, SURESH |
| 5R01CA122256-02 | MOLINSKI, TADEUSZ F. | UNIVERSITY OF CALIFORNIA SAN DIEGO | Nanoscale-Natural Products Chemistry | LEES, ROBERT |
| 1R01CA124414-01A1 | MONGA, SATDARSHAN | UNIVERSITY OF PITTSBURGH AT PITTSBURGH | BETA-CATENIN AS A THERAPEUTIC TARGET IN HEPATOCELLULAR CANCER | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA130378-01 | MONTICELLO, DANIEL J | MOLECULAR LOGIX, INC. | Improving the pharmacokinetics of a new protein-based Pan-HER antagonist. | SONG, MIN-KYUNG |
| 1R43CA121620-01A1 | MONTICELLO, DANIEL J | MOLECULAR LOGIX, INC. | Insulin-like Growth Factor Receptor Antagonists | LEES, ROBERT |
| 5R01CA121138-02 | MOOBERRY, SUSAN L | SOUTHWEST FOUNDATION FOR BIOMEDICAL RES | Taccalonolides: Mechanisms of Action and Cellular Resistance | FU, YALI |
| 1R01CA127622-01 | MOORE, BRADLEY S | UNIVERSITY OF CALIFORNIA SAN DIEGO | Salinosporamide Biosynthesis and Engineering | FU, YALI |
| 1R01CA118678-01A2 | MOR, GIL G | YALE UNIVERSITY | Apoptotic regulators in ovarian cancer | SONG, MIN-KYUNG |
| 5R01CA027605-27 | MORAN, RICHARD G | VIRGINIA COMMONWEALTH UNIVERSITY | NUCLEOTIDE DEPRIVATION-BASED SELECTIVE THERAPEUTICS | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA125871-01A1 | MORGAN, LEE ROY | DEKK-TEC, INC. | Camptothecin Analogs for Cancer Therapy | LEES, ROBERT |
| 5R44CA094566-03 | MORGAN, LEE ROY | DEKK-TEC, INC. | Clinical Development of 4-Hydroperoxyifosfamide | FU, YALI |
| 1R15CA122044-01A1 | MORIDANI, MAJID Y | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER | A tyrosinase-targeted drug design for the treatment of melanoma | SONG, MIN-KYUNG |
| 5R01CA070338-11 | MORROW, CHARLES S | WAKE FOREST UNIVERSITY HEALTH SCIENCES | MRP/GST Synergy in MDR | SONG, MIN-KYUNG |
| 1R01CA121327-01A1 | MOTZER, ROBERT J | SLOAN-KETTERING INSTITUTE FOR CANCER RES | Molecular Basis Of Renal Cell Carcinoma Response to SU11428 | SONG, MIN-KYUNG |
| 1R41CA128152-01A1 | MOUSA, SHAKER A | VASCULAR VISION PHARMACEUTICALS COMPANY | Nanoparticle targeting of cathepsin-L inhibitor and doxorubicin in breast cancer | FU, YALI |
| 7R01CA115197-03 | MUMPER, RUSSELL J | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | EGFR Targeted Nanoparticles to Overcome Paclitaxel Resistant Breast Cancer | FU, YALI |
| 5R01CA115197-02 | MUMPER, RUSSELL J | UNIVERSITY OF KENTUCKY | EGFR Targeted Nanoparticles to Overcome Paclitaxel Resistant Breast Cancer | FU, YALI |
| 5R21CA121074-02 | MURPHY, LAURA L | SOUTHERN ILLINOIS UNIVERSITY CARBONDALE | Anti-Cancer Ginsenosides: Their Interactions and Mechanisms of Action | FU, YALI |
| 5R01CA047148-20 | MYERS, ANDREW G | HARVARD UNIVERSITY | Synthesis and Study of Natural and Non-natural Antiproliferative Agents | LEES, ROBERT |
| 5R01CA098787-04 | NAGLE, DALE G | UNIVERSITY OF MISSISSIPPI | ANTICANCER DRUG DISCOVERY THAT TARGETS TUMOR HYPOXIA | FU, YALI |
| 5R01CA112175-02 | NATARAJAN, MOHAN | UNIVERSITY OF TEXAS HLTH SCI CTR SAN ANT | ENHANCED APOPTOSIS BY TARGETING PROTEIN REDOX STATUS | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA118871-01A1 | NATHANSON, KATHERINE L | UNIVERSITY OF PENNSYLVANIA | Somatic genetic predictors of response to therapy in metastatic melanoma | SONG, MIN-KYUNG |
| 1R01CA120188-01A2 | NEAMATI, NOURI | UNIVERSITY OF SOUTHERN CALIFORNIA | Integrin avb3 targeted drug design, delivery, and imaging | FU, YALI |
| 1R41CA130495-01 | NEIGHBORS, JEFFREY D | TERPENOID THERAPEUTICS, INC. | Preclinical Development of Geranylgeranyl Disphosphate Synthase Inhibitors as Ant | LEES, ROBERT |
| 1R41CA126020-01 | NEIGHBORS, JEFFREY D | TERPENOID THERAPEUTICS, INC. | Novel Glioblastoma Therapeutics | LEES, ROBERT |
| 5R01CA100101-02 | NICOLAOU, K C | SCRIPPS RESEARCH INSTITUTE | SYNTHESIS OF ANTICANCER AGENTS | LEES, ROBERT |
| 1R21CA128696-01 | NILSEN-HAMILTON, MARIT | IOWA STATE UNIVERSITY | Drugcarts to Combat Drug Resistance | FU, YALI |
| 5R01CA082313-07 | NITISS, JOHN L. | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | DNA Repair and Antitopoisomerase Drug Effects | ARYA, SURESH |
| 5R01CA094107-06 | O'BRIEN, THOMAS G | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | Polyamine-based Therapy of Squamous Cell Carcinoma | WOLPERT, MARY K. |
| 2R01CA088932-06A1 | OGRETMEN, BESIM | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Regulation of Telomerase by Ceramide in Lung Cancer | ARYA, SURESH |
| 5R01CA103314-17 | OJIMA, IWAO | STATE UNIVERSITY NEW YORK STONY BROOK | Taxane and Taxoid Chemotherapeutic Agents | LEES, ROBERT |
| 1R21CA129388-01 | OLENYUK, BOGDAN | UNIVERSITY OF ARIZONA | Modular Dendritic Integrin Antagonists for Cancer Therapy | LEES, ROBERT |
| 5R01CA114567-02 | OLSON, JAMES M | FRED HUTCHINSON CANCER RESEARCH CENTER | Targeted therapy in ex vivo medulloblastoma/PNET | SONG, MIN-KYUNG |
| 1R43CA132235-01 | OLSON, KEITH | DISCOVERX CORPORATION | EFC assay to measure Allosteric Regulation of Protein Kinases | SONG, MIN-KYUNG |
| 1R43CA130236-01 | OLSON, KEITH | DISCOVERX CORPORATION | Development of an EFC Assay to Measure Growth Factor Receptor Dimer Formation for Drug Screening | SONG, MIN-KYUNG |
| 1R01CA121797-01A1 | ONYUKSEL, HAYAT | UNIVERSITY OF ILLINOIS AT CHICAGO | Phospholipid Nanocarriers Improve Chemotherapy by Targeted Drug Delivery | FU, YALI |
| 5R01CA104561-04 | OPIPARI, ANTHONY W | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Novel Compounds and a Mitochondria Target Against Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA102278-04 | ORLOWSKI, ROBERT Z | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Dual Proteasome and MAPK Inhibition in Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109711-03 | OUPICKY, DAVID | WAYNE STATE UNIVERSITY | Gene Delivery Modulated by Redox Potential Gradients | FU, YALI |
| 5R44CA099435-05 | OWENS, ALBERT H. | FASGEN, INC. | Fatty Acid Synthase Inhibitors: Ovarian Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 7R21CA116641-02 | PANYAM, JAYANTH | UNIVERSITY OF MINNESOTA TWIN CITIES | DUAL-AGENT NANOPARTICLES TO OVERCOME DRUG RESISTANCE | FU, YALI |
| 1R21CA116641-01A2 | PANYAM, JAYANTH | WAYNE STATE UNIVERSITY | DUAL-AGENT NANOPARTICLES TO OVERCOME DRUG RESISTANCE | FU, YALI |
| 5R01CA123037-02 | PARSONS, SARAH J | UNIVERSITY OF VIRGINIA CHARLOTTESVILLE | c-Src/EGF Receptors Interactions and Therapeutic Resistance in Breast Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA116099-02 | PASQUALE, ELENA B | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | The EphB4 Receptor as a Novel Breast Cancer Target | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA113639-02 | PEARSE, ROGER N | WEILL MEDICAL COLLEGE OF CORNELL UNIV | Neurotrophin Signaling in Multiple Myeloma | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA071976-12 | PEGG, ANTHONY E | PENNSYLVANIA STATE UNIV HERSHEY MED CTR | Alkyltransferase Inhibitors for Cancer Chemotherapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA114475-03 | PELLETIER, JERRY | MC GILL UNIVERSITY | High Throughput Assays Targeting Ribosome Recruitment | ARYA, SURESH |
| 5R01CA109619-03 | PENDYALA, LAKSHMI | ROSWELL PARK CANCER INSTITUTE CORP | Polyamine Catabolism in Platinum Drug Action | WOLPERT, MARY K. |
| 1R01CA129632-01 | PERTSEMLIDIS, ALEXANDER | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | microRNA regulation of drug sensitivity in non-small cell lung cancer | ARYA, SURESH |
| 5R01CA118498-02 | PETERSON, RANDALL T | MASSACHUSETTS GENERAL HOSPITAL | Chemical genetic modifiers of acute myelogenous leukemia | SONG, MIN-KYUNG |
| 1R01CA125063-01 | PETRENKO, VALERY A | AUBURN UNIVERSITY AT AUBURN | Drug Delivery Carriers Targeted to Breast Tumor by Fusion Phage Proteins | FU, YALI |
| 2R56CA090441-06A1 | PETTIT, GEORGE R | ARIZONA STATE UNIVERSITY-TEMPE CAMPUS | Molecular Target Focused Discovery of Anticancer Drugs | FU, YALI |
| 5R01CA110246-04 | PHILLIPS, ANDREW J | UNIVERSITY OF COLORADO AT BOULDER | Total Synthesis of Bioactive Compounds | LEES, ROBERT |
| 5R01CA100011-04 | PIEPER, RUSS O | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | P38, G2 Arrest, and Temozolomide Resistance in Gliomas | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA102121-05 | PIZZORNO, GIUSEPPE | NEVADA CANCER INSTITUTE | Role of Uridine Phosphorylase in Cancer Treatment | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA028596-26 | PLUNKETT, WILLIAM K | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Biochemical Basis for Therapeutic Activity | ARYA, SURESH |
| 5R01CA098817-05 | PONNAZHAGAN, SELVARANGAN | UNIVERSITY OF ALABAMA AT BIRMINGHAM | Gene Therapy for Prostate Cancer | WOLPERT, MARY K. |
| 5R01CA076428-09 | PORTER, CARL W | ROSWELL PARK CANCER INSTITUTE CORP | Antiproliferative Potential of Polyamine Catabolism | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA022153-31 | PORTER, CARL W | ROSWELL PARK CANCER INSTITUTE CORP | POLYAMINE ANALOG REGULATION OF CELL CYCLE AND APOPTOSIS | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA108775-03 | POTTER, PHILIP M | ST. JUDE CHILDREN'S RESEARCH HOSPITAL | Selective Inhibitors to Improve CPT-11 Therapy | SONG, MIN-KYUNG |
| 5R01CA077204-09 | POWIS, GARTH | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Thioredoxin Inhibition of Apoptosis and Cancer Treatment | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA061015-10 | POWIS, GARTH | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Novel Inhibitors of Akt Signaling in Pancreatic Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5U19CA052995-19 | POWIS, GARTH | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Cancer Drugs Active Against Stress Signaling Pathways | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA107506-03 | PRABHAKAR, BELLUR S | UNIVERSITY OF ILLINOIS AT CHICAGO | Novel human gene-IG20-potential role in cancer therapy | ARYA, SURESH |
| 5R01CA109542-03 | PRENDERGAST, GEORGE C | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | IDO Inhibitors for Combinatorial Cancer Therapy | LEES, ROBERT |
| 5R01CA114422-02 | PUDUVALLI, VINAY K | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Efficacy and toxicity of TRAIL against gliomas | SONG, MIN-KYUNG |
| 5R01CA073808-11 | RAINES, RONALD T | UNIVERSITY OF WISCONSIN MADISON | RIBONUCLEASES IN CANCER CHEMOTHERAPY | WOLPERT, MARY K. |
| 5R01CA092393-05 | RAO, JASTI S | UNIVERSITY OF ILLINOIS AT CHICAGO | Suppression of glioma invasion by a bicistronic constuct | WOLPERT, MARY K. |
| 5R01CA106625-05 | RAO, U SUBRAHMANYESWARA | TEXAS TECH UNIVERSITY HEALTH SCIS CENTER | A Novel Ring Finger Protein in Cancer Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R21CA113813-02 | RAUCHER, DRAZEN | UNIVERSITY OF MISSISSIPPI MEDICAL CENTER | Targeted Delivery of c-Myc Inhibitory Polypeptides | FU, YALI |
| 5R01CA101438-09 | RAWAL, VIRESH H. | UNIVERSITY OF CHICAGO | Stereocontrolled Synthesis of Bioactive Alkaloids | LEES, ROBERT |
| 1R01CA124488-01 | RAYCHAUDHURI, PRADIP | UNIVERSITY OF ILLINOIS AT CHICAGO | Cell Penetrating Peptide Inhibitor of FoxM1 in Hepatocellular Carcinoma Treatment | ARYA, SURESH |
| 1R03CA131827-01 | READER, JOHN | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Evolution of aptamers against pancreatic tumor vasculature | LEES, ROBERT |
| 5R01CA109820-04 | REDDY, E PREMKUMAR | TEMPLE UNIVERSITY | Targeting Cell Cycle Machinery For Cancer Therapy | ARYA, SURESH |
| 5R01CA098468-05 | REDINBO, MATTHEW R | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Improving CPT-11 Efficacy Using Structural Biology | FU, YALI |
| 5U19CA113318-03 | REED, JOHN C | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | Apoptosis-Based Cancer Drug Discovery | ARYA, SURESH |
| 5R01CA113677-03 | REGAN, LYNNE J. | YALE UNIVERSITY | HTP assays of inhibitors of protein-protein interactions | SONG, MIN-KYUNG |
| 1R01CA129623-01 | REHEMTULLA, ALNAWAZ | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Molecular Imaging of Phospho-FADD and its role in resistance to therapy | SONG, MIN-KYUNG |
| 1R03CA127842-01 | REPASKY, ELIZABETH A | ROSWELL PARK CANCER INSTITUTE CORP | Predicting Response of Pancreatic Tumors to Therapy | SONG, MIN-KYUNG |
| 5R01CA116021-03 | RICHMOND, ANN | VANDERBILT UNIVERSITY | Targeting the NF-kappaB Pathway in Melanoma | ARYA, SURESH |
| 5R01CA105607-04 | ROBERTS, THOMAS M | DANA-FARBER CANCER INSTITUTE | Genomic-wide Kinase Sequencing of Pediatric Brain Tumors | ARYA, SURESH |
| 1R01CA120429-01A1 | RODRIGUEZ-RODRIGUEZ, LORNA | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Regulation of MDR1 Expression and Drug Resistance by CD44 | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA102102-03 | ROHR, JURGEN | UNIVERSITY OF KENTUCKY | BIOSYNTHETIC KEY STEPS OF ANGUCYCLINE ANTITUMOR DRUGS | FU, YALI |
| 5R01CA081571-07 | ROKITA, STEVEN E | UNIVERSITY OF MARYLAND COLLEGE PK CAMPUS | Target Promoted Alkylation of Nucleic Acids | LEES, ROBERT |
| 5R01CA106582-04 | ROMO, DANIEL | TEXAS A&M UNIVERSITY SYSTEM | NOVEL ANTICANCER FATTY ACID SYNTHASE INHIBITORS | LEES, ROBERT |
| 5R01CA085915-07 | ROSEN, STEVEN T | NORTHWESTERN UNIVERSITY | Adenosine Analogs: Therapeutics for Hematologic Cancers | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA112310-03 | ROSNER, MARSHA R | UNIVERSITY OF CHICAGO | Role of Raf Kinase Inhibitory Protein in Prostate Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109278-04 | ROSNER, MARSHA R | UNIVERSITY OF CHICAGO | Modulation of Head and Neck Cancer by Protein Kinase C | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA114441-03 | ROSS, DAVID | UNIVERSITY OF COLORADO DENVER/HSC AURORA | NQO1 Inhibitors and Pancreatic Cancer Therapy | SONG, MIN-KYUNG |
| 5R01CA051210-17 | ROSS, DAVID | UNIVERSITY OF COLORADO DENVER/HSC AURORA | Biochemical and Molecular Studies on DT Diaphorase | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA081635-10 | RYCHNOVSKY, SCOTT D. | UNIVERSITY OF CALIFORNIA IRVINE | Synthesis of anticancer agents using Prins cyclization | LEES, ROBERT |
| 5R01CA101743-05 | SAFA, AHMAD R | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Role of Proteinase-3 in Apoptosis and Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA124998-01A1 | SAFE, STEPHEN H | TEXAS A&M UNIVERSITY HEALTH SCIENCE CTR | NUR77 Agonists: New Targets for Pancreatic Cancer Chemotherapy | ARYA, SURESH |
| 5R01CA112337-03 | SAFE, STEPHEN H | TEXAS A&M UNIVERSITY SYSTEM | Colon Cancer Inhibition by a Class of PPARgamma Agonists | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA108718-04 | SAFE, STEPHEN H | TEXAS A&M UNIVERSITY SYSTEM | Inhibition of Pancreatic Cancer by New PPARgamma Agonis* | ARYA, SURESH |
| 5R01CA100121-04 | SAFO, MARTIN K | VIRGINIA COMMONWEALTH UNIVERSITY | Rational Design of Novel Estrogen Receptor Antagonists | LEES, ROBERT |
| 1R01CA125541-01 | SALGIA, RAVI | UNIVERSITY OF CHICAGO | Studies of a Novel Therapeutic Target in Non-Small Cell Lung Cancer (NSCLC) | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA100750-04 | SALGIA, RAVI | UNIVERSITY OF CHICAGO | Role of c-Met in SCLC and Potential for Novel Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA101870-05 | SARKAR, FAZLUL H. | WAYNE STATE UNIVERSITY | Targeting Akt/NF-kappa beta for Pancreatic Cancer Therapy | ARYA, SURESH |
| 5R01CA122112-02 | SARTORELLI, ALAN C | YALE UNIVERSITY | Hypoxia-Activated O6-Benzylguanine Prodrugs | LEES, ROBERT |
| 5R01CA090671-06 | SARTORELLI, ALAN C | YALE UNIVERSITY | Development of Anticancer 1,2-Bis(sulfonyl)hydrazines | LEES, ROBERT |
| 1R01CA115527-01A2 | SAWICKI, JANET A | LANKENAU INSTITUTE FOR MEDICAL RESEARCH | Targeting Nanoparticle DNA Delivery to Prostate Tumors | FU, YALI |
| 1R43CA128137-01 | SCHELLENBERGER, VOLKER | AMUNIX, INC. | Drug binding microprotein domains for targeted delivery of cytotoxic drugs | FU, YALI |
| 2R01CA072444-11A1 | SCHRAMM, VERN L. | YESHIVA UNIVERSITY | Ricin-Mechanism, Transition State and Inhibitor Design | LEES, ROBERT |
| 5R01CA098527-04 | SCHROIT, ALAN J | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Tumor therapy with antiangiogenic beta-2-glycoprotein 1 | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA098456-05 | SCHWARTZ, EDWARD L | MONTEFIORE MEDICAL CENTER (BRONX, NY) | Anti-angiogenic actions of taxotere | FU, YALI |
| 1P01CA118210-01A1 | SEBTI, SAID M | H. LEE MOFFITT CANCER CTR & RES INST | Targeting Signal Transduction Pathways for Cancer Drug Discovery | LEES, ROBERT |
| 5R01CA106829-04 | SEBTI, SAID M | H. LEE MOFFITT CANCER CTR & RES INST | Growth Factor as Anti-angiogenesis Agents | LEES, ROBERT |
| 5U19CA067771-13 | SEBTI, SAID M | H. LEE MOFFITT CANCER CTR & RES INST | Inhibitors of Rho function as novel cancer therapeutics | LEES, ROBERT |
| 5R01CA101983-05 | SEDWICK, W DAVID | CASE WESTERN RESERVE UNIVERSITY | Transcriptional Regulation in hMLH1-Silenced Colon Cells | ARYA, SURESH |
| 1R43CA124179-01A1 | SERRERO, GINETTE | A AND G PHARMACEUTICAL, INC. | Novel Targeted Therapy for Breast Cancer | FU, YALI |
| 1R01CA127380-01 | SETH, PREM K | EVANSTON NORTHWESTERN HEALTHCARE | Oncolytic Adenovirus-sTGFbetaRIIFc Targeting Breast Cancer Bone Metastasis | ARYA, SURESH |
| 5R01CA115830-03 | SETTLEMAN, JEFFREY E | MASSACHUSETTS GENERAL HOSPITAL | Gefitinib-sensitive EGF receptor mutants in lung cancer | SONG, MIN-KYUNG |
| 5R01CA112021-03 | SGROI, DENNIS C | MASSACHUSETTS GENERAL HOSPITAL | A Novel Breast Cancer Biomarker | SONG, MIN-KYUNG |
| 1R43CA128141-01 | SHAHAN, MARK N | QUINTESSENCE BIOSCIENCES, INC. | Improving Efficacy of RNase Cancer Therapy by Pharmacokinetics | FU, YALI |
| 1R43CA119602-01A1 | SHAHAN, MARK N | QUINTESSENCE BIOSCIENCES, INC. | Cytotoxic Ribonucleases in Antibody-Drug Conjugates | LEES, ROBERT |
| 1R01CA125240-01A1 | SHAIR, MATTHEW D | HARVARD UNIVERSITY | Synthesis and Mechanisms of Bioactive Natural Products | LEES, ROBERT |
| 5R01CA120215-02 | SHAPIRO, PAUL S | UNIVERSITY OF MARYLAND BALTIMORE | Substrate specific ERK docking domain inhibitors | LEES, ROBERT |
| 5U19CA113297-03 | SHEN, BEN | UNIVERSITY OF WISCONSIN MADISON | UWCCC National Cooperative Drug Discovery Group for Can* | LEES, ROBERT |
| 5R01CA106150-04 | SHEN, BEN | UNIVERSITY OF WISCONSIN MADISON | "AT-less" Type I Polyketide Synthases | FU, YALI |
| 5R01CA094426-10 | SHEN, BEN | UNIVERSITY OF WISCONSIN MADISON | Biosynthesis of hybrid peptide-polyketide antibiotics | FU, YALI |
| 5R01CA078747-08 | SHEN, BEN | UNIVERSITY OF WISCONSIN MADISON | Enediyne Biosynthesis and Engineering | FU, YALI |
| 1R43CA119503-01A2 | SHENOY, NARMADA R | ARAVASC, INC. | Drug-eluting Tracheobronchial Stents to treat Obstruction caused by Lung Cancer | FU, YALI |
| 5R01CA108874-02 | SHERMAN, DAVID H | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Biosynthetic Analysis of Marine Cyanobacterial Pathways | FU, YALI |
| 2R56CA076581-09 | SHEWACH, DONNA S. | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Enhancing Suicide Gene Therapy Through Mechanism-Based Approaches | ARYA, SURESH |
| 5R01CA109366-02 | SHIM, HYUN S | EMORY UNIVERSITY | Development of anti-CXCR4 compounds as anti-metastatic, angiogenic drug | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA106954-04 | SHRIDHAR, VIJI | MAYO CLINIC COLL OF MEDICINE, ROCHESTER | Role of HSulf-1 Loss in Apoptosis and Drug Resistance | ARYA, SURESH |
| 5R01CA104278-04 | SHUREIQI, IMAD | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Molecular Targeting of 15-Lipoxygenase-1 in Colon Cancer | ARYA, SURESH |
| 1R01CA127263-01 | SIDDIK, ZAHID H | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Checkpoint Response and Platinum Drug Sensitivity | WOLPERT, MARY K. |
| 1R01CA114037-01A2 | SIKIC, BRANIMIR I | STANFORD UNIVERSITY | Taxane Resistance in Breast and Ovarian Cancer Cells | SONG, MIN-KYUNG |
| 5R01CA104593-04 | SILBER, JOHN R | UNIVERSITY OF WASHINGTON | Ape1, oxidative stress and glioma alkylator resistance | FORRY-SCHAUDIES, SUZANNE |
| 7R01CA098804-05 | SIMPKINS, HENRY | FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH | Dihydrodiol dehydrogenase mediates cisplatin resistance | WOLPERT, MARY K. |
| 7R33CA105514-04 | SIMS, CHRISTOPHER E | UNIVERSITY OF NORTH CAROLINA CHAPEL HILL | Assaying Tyrosine Kinase Activity: A New Paradigm | SONG, MIN-KYUNG |
| 5R01CA070329-11 | SMITH, AMOS B | UNIVERSITY OF PENNSYLVANIA | Synthesis of Spongistatin Antitumor Agents | LEES, ROBERT |
| 5R01CA019033-31 | SMITH, AMOS B | UNIVERSITY OF PENNSYLVANIA | Anticancer Agents--Structure and Synthesis | LEES, ROBERT |
| 1R01CA122226-01A1 | SMITH, CHARLES D | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Sphingosine Kinase as a Target for Cancer Therapy | LEES, ROBERT |
| 5R01CA075248-12 | SMITH, CHARLES D. | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Acyltransferase Inhibitors as Anti Ras Agents | FORRY-SCHAUDIES, SUZANNE |
| 1R21CA125445-01 | SMITH, JILL P | PENNSYLVANIA STATE UNIV HERSHEY MED CTR | Effects of silencing RNAs for gastrin and CCK on human pancreatic cancer | ARYA, SURESH |
| 5R01CA097107-04 | SNAPKA, ROBERT M | OHIO STATE UNIVERSITY | PROTEOMICS OF TOPOISOMERASE-DNA CLEAVAGE COMPLEXES | FU, YALI |
| 5R01CA064945-13 | SOPRANO, KENNETH J | TEMPLE UNIVERSITY | RETINOIDS FOR TREATMENT OF OVARIAN CARCINOMA | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA119170-02 | SORSCHER, ERIC J | UNIVERSITY OF ALABAMA AT BIRMINGHAM | Tumor Sensitization to Purine Analogs by E. coli PNP | ARYA, SURESH |
| 5R01CA113746-02 | SRIVASTAVA, D K | NORTH DAKOTA STATE UNIVERSITY | Catalysis and Inhibition of Gelatinases | LEES, ROBERT |
| 5R01CA108415-08 | STEIN, C A | MONTEFIORE MEDICAL CENTER (BRONX, NY) | Mechanism of Action of G3139 | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109474-02 | STEIN, RHONA | CTR FOR MOLECULAR MEDICINE/IMMUNOLOGY | Doxorubicin-Immunoconjugate Therapy of Non-Hodgkin's Lymphoma | FU, YALI |
| 1R01CA129009-01 | STEWART, ALEXANDER K | MAYO CLINIC COLL OF MED, MAYO CLINIC AZ | The Molecular Basis for Bortezomib Activity | SONG, MIN-KYUNG |
| 2R01CA097061-05A1 | STOCKWELL, BRENT R | COLUMBIA UNIV NEW YORK MORNINGSIDE | Chemical genetic profiling of engineered tumor cells | SONG, MIN-KYUNG |
| 2R01CA097328-05A1 | STODDARD, BARRY L | FRED HUTCHINSON CANCER RESEARCH CENTER | Engineering enzymes for anti-tumor suicide gene therapy | ARYA, SURESH |
| 1R21CA128452-01 | STOJANOVIC, MILAN | COLUMBIA UNIVERSITY HEALTH SCIENCES | Therapeutic Self-Assembly of Recognition Elements on Cell Surfaces | SONG, MIN-KYUNG |
| 5R01CA107570-04 | STRAUBINGER, ROBERT M | STATE UNIVERSITY OF NEW YORK AT BUFFALO | Drug carrier of blood/tumor/brain permeability | FU, YALI |
| 5R01CA099003-06 | STRICH, RANDY S | UNIV OF MED/DENT NJ-SCH OSTEOPATHIC MED | Role of the Oxidative Stress Pathway in Drug Resistance | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA100074-04 | STRUCK, ROBERT F. | CANCERMEDICA, LLC | 4-Peroxycyclophosphamides for Brain Tumor Therapy | LEES, ROBERT |
| 1R01CA117942-01A2 | STUDZINSKI, GEORGE P | UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL | VITAMIN D PLANT ANTIOXIDANT SILIBININ IN LEUKEMIA TRANSLATIONAL STUDY | FU, YALI |
| 1R01CA123007-01A1 | STURLA, SHANA J | UNIVERSITY OF MINNESOTA TWIN CITIES | Covalent Modification of DNA and Protein by Bioactivated Antitumor Acylfulvenes | LEES, ROBERT |
| 2R01CA059515-11A2 | SULIKOWSKI, GARY A | VANDERBILT UNIVERSITY | Synthetic/Mechanistic Investigations of Antitumor Agents | LEES, ROBERT |
| 1R01CA120023-01A2 | SUN, DUXIN | OHIO STATE UNIVERSITY | An integrated system for tumor detection and targeted drug therapy of cancer | FU, YALI |
| 5R01CA118450-02 | SUN, SHI-YONG | EMORY UNIVERSITY | Enhancing the mTOR-targeted cancer therapy | FORRY-SCHAUDIES, SUZANNE |
| 1R21CA128529-01 | SUN, SHOUHENG | BROWN UNIVERSITY | Controlled Functionalization of Composite Magnetic Nanoparticles for Targeted Del | FU, YALI |
| 5R01CA107268-04 | SZOKA, FRANCIS C | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | Pharmacology of Targeted Therapy to Brain Tumors | SONG, MIN-KYUNG |
| 5R01CA106767-04 | TAN, MING T. | UNIVERSITY OF MARYLAND BALTIMORE | Design & Analysis of Preclinical Combination Studies | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA106429-03 | TANG, CAREEN K | GEORGETOWN UNIVERSITY | Molecular Mechanisms of Blockage of ErbB receptors | SONG, MIN-KYUNG |
| 5R01CA097255-07 | TANG, XAO X | UNIVERSITY OF ILLINOIS AT CHICAGO | Molecular Therapeutics of Neuroblastoma | ARYA, SURESH |
| 1R01CA125636-01A1 | TANIGUCHI, TOSHIYASU | FRED HUTCHINSON CANCER RESEARCH CENTER | The Fanconi Anemia-BRCA Pathway And Chemosensitivity of Human Cancer | ARYA, SURESH |
| 1R41CA117259-01A2 | TEW, KENNETH D. | NOVELOS THERAPEUTICS, INC. | PRECLINICAL DEVELOPMENT OF A GLUTATHIONE BASED CANCER DRUG | SONG, MIN-KYUNG |
| 5R01CA085660-09 | TEW, KENNETH D. | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Glutathione S- Transferases in Drug and Stress Response | SONG, MIN-KYUNG |
| 5R01CA080163-09 | THOMAS, T J | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Novel Oligonucleotide Delivery Vehicles for Gene Tharapy | WOLPERT, MARY K. |
| 5R01CA112427-02 | THOMPSON, DAVID H | PURDUE UNIVERSITY WEST LAFAYETTE | Development of an ICMT Supported Membrane Sensor | SONG, MIN-KYUNG |
| 5R01CA084374-09 | THORSON, JON SCOTT | UNIVERSITY OF WISCONSIN MADISON | Studies on Calicheamicin Biosynthesis and Resistance | FU, YALI |
| 5R21CA116846-02 | TIAN, JIDE | UNIVERSITY OF CALIFORNIA LOS ANGELES | A Derivative of Oleanolic Acid: Anti-HCC Activity | SONG, MIN-KYUNG |
| 5R01CA092160-07 | TIGYI, GABOR J | UNIVERSITY OF TENNESSEE HEALTH SCI CTR | Ligand Recognition by Phospholipid Growth Factor Receptors | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA122914-01A1 | TONETTI, DEBRA A | UNIVERSITY OF ILLINOIS AT CHICAGO | PKC Alpha as a Marker for Logical Therapeutic Approaches to Breast Cancer | SONG, MIN-KYUNG |
| 1R43CA128164-01 | TONG, YOUZHI | ANGION BIOMEDICA CORPORATION | Novel c-Met and Tie-2 antagonists against human glioma | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA073839-09 | TOOLE, BRYAN P | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Inhibition of Tumor Progression by Hyaluronan Oligomers | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA121838-02 | TORCHILIN, VLADIMIR P | NORTHEASTERN UNIVERSITY | MULTIFUNCTIONAL STIMULI-SENSITIVE PHARMACEUTICAL NANOCARRIERS | FU, YALI |
| 1R01CA129447-01 | TRENT, JEFFREY M | TRANSLATIONAL GENOMICS RESEARCH INST | Genomic Analysis of Tumor Context Vulnerabilities in Human Metastatic Melanoma | SONG, MIN-KYUNG |
| 5R01CA113735-03 | TRENT, JOHN O | UNIVERSITY OF LOUISVILLE | Development of Nucleolin targeted Anticancer Compounds | LEES, ROBERT |
| 5R01CA094012-05 | TSE, CHUNG-MING | JOHNS HOPKINS UNIVERSITY | Nucleoside Transporters: Pharmacology of hENT3 and hCNT3 | FORRY-SCHAUDIES, SUZANNE |
| 2R01CA082741-06A2 | TURCHI, JOHN J | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Recognition and Repair of Cisplatin-DNA Damage | WOLPERT, MARY K. |
| 5R01CA106439-04 | TURKSON, JAMES K | UNIVERSITY OF CENTRAL FLORIDA | STATs as a Novel Approach to Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 1R01CA127562-01A1 | UENO, NAOTO T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Development of PEA 15 as a Targeted Therapeutic Gene for Ovarian Cancer | ARYA, SURESH |
| 1R01CA123318-01A1 | UENO, NAOTO T | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Markers of sensivity to the EGFR inhibitor erlotinib in breast cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA109277-03 | UESUGI, MOTONARI | BAYLOR COLLEGE OF MEDICINE | Small-molecule analysis of signaling pathways | LEES, ROBERT |
| 5R43CA119556-02 | UNGER, GRETCHEN M | GENESEGUES, INC. | Tumor-targeted delivery of siRNA via sub-50 nanometer capsules | FU, YALI |
| 5R01CA100851-04 | VALERIOTE, FREDERICK A | HENRY FORD HEALTH SYSTEM | Discovery of Anticancer Drugs from Cyanobacteria | FU, YALI |
| 5R01CA092143-05 | VALERIOTE, FREDERICK A | HENRY FORD HEALTH SYSTEM | Discovery/Development of Anticancer Agents from Plants | FU, YALI |
| 5R01CA108637-03 | VALLERA, DANIEL A | UNIVERSITY OF MINNESOTA TWIN CITIES | Experimental Therapeutics for Brain Cancer | SONG, MIN-KYUNG |
| 1R01CA116804-01A2 | VAN MEIR, ERWIN G | EMORY UNIVERSITY | Targeting Glioblastoma Using Novel Small Molecule HIF-1 Pathway Inhibitors | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA094926-04 | VARANI, GABRIELE | UNIVERSITY OF WASHINGTON | Structure of ribonucleoprotein: telomerase | FU, YALI |
| 5R01CA017918-33 | VEDEJS, EDWIN | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Cytotoxic Nitrogen Heterocycles | LEES, ROBERT |
| 5R01CA102791-04 | VINOGRADOV, SERGUEI V | UNIVERSITY OF NEBRASKA MEDICAL CENTER | Polymer-Nucleotide Complexes with Cytotoxic Activity | FU, YALI |
| 5R01CA102218-04 | VOELKEL-JOHNSON, CHRISTINA | MEDICAL UNIVERSITY OF SOUTH CAROLINA | TRAIL-induced apoptosis in prostate cancer | ARYA, SURESH |
| 5P01CA078045-09 | VOGT, PETER K | SCRIPPS RESEARCH INSTITUTE | Combinatorial Chemistry and Cancer Target | SONG, MIN-KYUNG |
| 2R01CA095031-06 | VON HOFF, DANIEL D | TRANSLATIONAL GENOMICS RESEARCH INST | Aurora Kinases as Therapeutic Targets in Pancreatic Cancer | ARYA, SURESH |
| 1R15CA122084-01A1 | VYVYAN, JAMES R | WESTERN WASHINGTON UNIVERSITY | Synthesis of (-)-cananodine, an alkaloid active against hepatocellular carcinoma | LEES, ROBERT |
| 1R21CA116826-01A2 | WANG, MARILENE B | BRENTWOOD BIOMEDICAL RESEARCH INSTITUTE | Curcumin suppression of head and neck cancer | FU, YALI |
| 5R01CA118208-02 | WANG, P. GEORGE | OHIO STATE UNIVERSITY | Chemical Glycobiology on Anthracyclines | LEES, ROBERT |
| 5R01CA121279-02 | WANG, SHAOMENG | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Non-Peptide Small-Molecule Inhibitors of the MDM2-p53 interaction | LEES, ROBERT |
| 5U19CA113317-03 | WANG, SHAOMENG | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Novel Small-Molecule Inhibitors of Bcl-2/Bcl-xL Protein* | SONG, MIN-KYUNG |
| 5R01CA109025-04 | WANG, SHAOMENG | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Design of SMAC Peptidomimetics and Nonpeptidic Mimetics | LEES, ROBERT |
| 5R01CA049248-18 | WAXMAN, DAVID J | BOSTON UNIVERSITY | Hepatic Metabolism of Anti-cancer Drugs | SONG, MIN-KYUNG |
| 1R43CA121653-01A1 | WEBB, ROBERT | AXONA, INC. | Calpain Inhibitors for Cancer Related Neuropathies | SONG, MIN-KYUNG |
| 5R01CA107331-02 | WEBER, DAVID JOSEPH | UNIVERSITY OF MARYLAND BALTIMORE | Restoration of Tumor Suppression Activity in Malignant Melanoma | LEES, ROBERT |
| 5R01CA034303-25 | WEINREB, STEVEN M. | PENNSYLVANIA STATE UNIVERSITY-UNIV PARK | Chemical Studies on Anticancer Natural Products | LEES, ROBERT |
| 5R01CA098605-05 | WEINTRAUB, STEVEN J | WASHINGTON UNIVERSITY | Rb,p53, Bcl-2 Proteins in Apoptosis | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA102321-05 | WEISS, WILLIAM A | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | Murine Neuroblastoma Models for Preclinical Therapeutics | SONG, MIN-KYUNG |
| 1R15CA122001-01A1 | WEISSBACH, HERBERT | FLORIDA ATLANTIC UNIVERSITY | Enhanced Killing of Cancer Cell by Sulindac and Oxidative Stress | ARYA, SURESH |
| 5R37CA031845-27 | WENDER, PAUL A | STANFORD UNIVERSITY | Synthetic Studies Related to Cancer Research/Treatment | LEES, ROBERT |
| 5R01CA031841-27 | WENDER, PAUL A | STANFORD UNIVERSITY | Synthetic Studies on Tumor Promoters and Inhibitors | LEES, ROBERT |
| 5P01CA072006-10 | WERB, ZENA | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | Proteases in Cancer Biology and Drug Development | FORRY-SCHAUDIES, SUZANNE |
| 1R43CA121496-01A2 | WHARTON, J TIM | LYNNTECH, INC. | Targeted Gene Therapy Using Synthetic Vectors | FU, YALI |
| 1R21CA123040-01A1 | WHITE, MICHAEL A | UNIVERSITY OF TEXAS SW MED CTR/DALLAS | Deriving Combinatorial Strategies for Therapy of Pancreatic Cancer | SONG, MIN-KYUNG |
| 5R01CA100922-04 | WIENTJES, M GUILLAUME | OHIO STATE UNIVERSITY | Enhanced Chemosensitivity of Pancreatic Cancer | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA100246-05 | WILKENS, STEPHAN | UPSTATE MEDICAL UNIVERSITY | STRUCTURE OF P-GLYCOPROTEIN BY ELECTRON MICROSCOPY | LEES, ROBERT |
| 5R01CA085419-08 | WILLIAMS, ROBERT MICHAEL | COLORADO STATE UNIVERSITY-FORT COLLINS | Synthesis of Et-743 Bioxalomycin and tetrazomine | LEES, ROBERT |
| 5R01CA070375-11 | WILLIAMS, ROBERT MICHAEL | COLORADO STATE UNIVERSITY-FORT COLLINS | Total Synthesis and Biosynthesis of Bioactive Substances | LEES, ROBERT |
| 5R01CA051875-16 | WILLIAMS, ROBERT MICHAEL | COLORADO STATE UNIVERSITY-FORT COLLINS | Synthesis and Mechanism of DNA Cross-linking of FR900482 | LEES, ROBERT |
| 7R01CA116571-03 | WOLF, DIETER A | BURNHAM INSTITUTE FOR MEDICAL RESEARCH | Small Molecule Inhibitors of P27 Proteolysis in Carcinomas | LEES, ROBERT |
| 1R01CA122484-01A1 | WONDRAK, GEORG T | UNIVERSITY OF ARIZONA | Targeting Glycolytic Control of Melanoma Cell Survival | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA122794-02 | WONG, KWOK-KIN | DANA-FARBER CANCER INSTITUTE | EGFRvIII Mutation in Tumorigenesis and Sensitivity to Tyrosine Kinase Inhibitors | FORRY-SCHAUDIES, SUZANNE |
| 5R21CA120017-02 | WOO, SAVIO L | MOUNT SINAI SCHOOL OF MEDICINE OF NYU | Anaerobic Bacteria as Therapeutic Agents for Metastatic | ARYA, SURESH |
| 5R01CA114294-02 | XING, CHENGGUO | UNIVERSITY OF MINNESOTA TWIN CITIES | Bcl-2 selective inhibitors: development and application to cancer treatment | LEES, ROBERT |
| 5R01CA108795-03 | XU, C WILSON | BIOLOGICAL RESEARCH INSTITUTE | Ras Peptide Aptamers | FORRY-SCHAUDIES, SUZANNE |
| 1R21CA128220-01 | XU, LIANG | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Tumor targeted RNAi by novel nanovectors for molecular therapy of prostate cancer | FU, YALI |
| 5R01CA121830-02 | XU, LIANG | UNIVERSITY OF MICHIGAN AT ANN ARBOR | Tumor-targeted silencing of Bcl-2/Bcl-xL by the self-assembled siRNA-nanovectors | FU, YALI |
| 5R01CA090351-07 | XU, WENQING | UNIVERSITY OF WASHINGTON | Crystallographic Studies of the Wnt Signaling Pathway | LEES, ROBERT |
| 2R56CA094084-06 | YAMAMOTO, MASATO | UNIVERSITY OF MINNESOTA TWIN CITIES | Enhanced CRAd for Pancreatic Cancer | ARYA, SURESH |
| 5R01CA066077-11 | YANG, JIN MING | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Regulation of Multidrug Resistance Phenotype | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA095643-05 | YANG, LILY | EMORY UNIVERSITY | IAPs As Novel Targets for Cancer Therapy | FORRY-SCHAUDIES, SUZANNE |
| 5R01CA114612-03 | YANG, VICTOR C | UNIVERSITY OF MICHIGAN AT ANN ARBOR | PTD-Mediated Protein or Drug Delivery for Cancer Therapy | FU, YALI |
| 5R01CA096636-05 | YI, TAOLIN | CLEVELAND CLINIC LERNER COL/MED-CWRU | Anti-Cancer Activities of PTPase Inhibitors | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA097813-05 | YOUNG, M RITA | MEDICAL UNIVERSITY OF SOUTH CAROLINA | Blocking angiogenesis by targeting PP-2A pathways | WOLPERT, MARY K. |
| 1R01 CA112042-01A1 | YOUNGREN, JACK F | UNIVERSITY OF CALIFORNIA SAN FRANCISCO | DAUs as IGF-1 Receptor Inhibitors in Breast Cancer | LEES, ROBERT |
| 5R01 CA123304-02 | YUNG, W K ALFRED | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Deciphering synergistic combinatorial targets in glioma | ARYA, SURESH |
| 5R01 CA083127-07 | YUNG, W K ALFRED | UNIVERSITY OF TEXAS MD ANDERSON CAN CTR | Triple Anti-Angiogenic Therapy for Brain Tumors | FORRY-SCHAUDIES, SUZANNE |
| 1R21 CA125467-01 | ZARE, RICHARD N | STANFORD UNIVERSITY | Nanoparticle Formation and Biodistribution for Optimizing Therapy | FU, YALI |
| 5R01 CA032779-24 | ZEMLICKA, JIRI | WAYNE STATE UNIVERSITY | Antitumor and Antiviral Nucleoside Analogues | LEES, ROBERT |
| 5R01 CA120221-02 | ZHANG, JIAN-TING | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Targeting the oligomerization of human ABCG2 | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA113384-01A2 | ZHANG, JIAN-TING | INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS | Targeting the amino terminal gate of human MRP1 | FORRY-SCHAUDIES, SUZANNE |
| 1R01 CA123391-01A1 | ZHENG, XIAOFENG S | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Growth Control and Anti-Cancer Mechanisms | FORRY-SCHAUDIES, SUZANNE |
| 5R01 CA099004-06 | ZHENG, XIAOFENG STEVEN | UNIV OF MED/DENT NJ-R W JOHNSON MED SCH | Genetic and Molecular Basis of Rapamycin Sensitivity | FORRY-SCHAUDIES, SUZANNE |
| 1R21 CA133865-01A2 | ZHOU, JIN-RONG | BETH ISRAEL DEACONESS MEDICAL CENTER | Oldenlandia diffusa for prostate cancer treatment | FU, YALI |
| 1R21 CA129793-01 | ZI, XIAOLIN | UNIVERSITY OF CALIFORNIA IRVINE | Lycopene & Docetaxel in Prostate Cancer: An IGF-I Receptor Targeting Approach | FU, YALI |
| 5R01 CA113579-03 | ZOU, XIANGHONG | OHIO STATE UNIVERSITY | Role and therapeutical potential of Cdk4/6 in B-lymphoma | ARYA, SURESH |
| 5R21 CA104297-02 | ZOU, YIYU | YESHIVA UNIVERSITY | A Tumor Specific Therapy Approach for Small Cell Lung Cancer | FU, YALI |